Isolation and identification of the constituents from Ruscus aculeatus L. and their in vitro activity by Barbic, Matej
 
 
Matej Barbič 
 
 
 
 
 
 
 
Isolation and identification of the constituents from Ruscus aculeatus L. 
and their in vitro activity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regensburg 2010 
  
 
Isolation and identification of the constituents from Ruscus aculeatus L. and 
their in vitro activity 
 
 
 
 
 
 
 
 
 
 
Von der Fakultät für Chemie und Pharmazie 
der Universität Regensburg 
genehmigte 
 
Dissertation 
 
zur Erlangung des akademischen Grades 
Doctor Rerum Naturalium 
(Dr. rer. nat.) 
 
 
 
 
 
 
 
 
 
vorgelegt von 
Matej Barbič 
aus Ivančna Gorica, Slowenien 
 
2010
  
  
 
Dekan:   Prof. Dr. Sigurd Elz 
Erster Gutachter:  Prof. Dr. Jörg Heilmann 
Zweiter Gutachter:  Prof. Dr. İhsan Çaliş 
 
Tag der Promotion:  12.01.2011 
 
ACKNOWLEDGEMENTS 
 I 
Following thesis was prepared under supervision of Prof. Dr. Jörg Heilmann at the 
Department of Pharmaceutical Biology, University of Regensburg. In vitro measurements of 
macromolecular permeability were performed by Mrs Elisabeth Willer at the Department of 
Pharmaceutical Biology (Prof. Dr. Angelika Vollmar), Ludwig-Maximilians University of 
Munich. Determination of the absolute stereochemistry of sugars by capillary electrophoresis 
was conducted by Mr Martin Rothenhöfer at the Department of Pharmaceutical and Medicinal 
Chemistry (Prof. Dr. Armin Buschauer), University of Regensburg. 
 
Acknowledgements 
It is a great pleasure to thank all the people who made this thesis possible. 
 
It is hard to overstate my gratitude to my Ph.D. supervisor, Prof. Dr. Jörg Heilmann. I would 
like to express my deep and sincere appreciation for giving me the opportunity to work on my 
thesis in such great research environment. Prof. Heilmann showed me the way to become a 
better scientist and always listened, when advice was needed. With his enthusiasm, cheerful 
character and excellent teaching ability, he always showed me new insights of the problem 
and gave me inspiration to find a clear and simple solution. 
 
I am also deeply grateful to my second supervisor, Dr. Guido Jürgenliemk, who coordinated 
and guided me through my research work. I have to thank him for pushing me hard and 
supporting me with his always fresh and glowing ideas, but also for being a good friend and a 
shoulder to lean on. On this occasion, I have to thank his lovely wife Uta, for tolerating some 
of the 'boys nights' at their home and for fruitful discussions about newest pharmaceutical 
products on the market. 
 
I owe my most sincere gratitude to Prof. Dr. İhsan Çaliş of the Faculty of Pharmacy, Near 
East University, Turkish Republic of Northern Cyprus. Prof. Çaliş showed me the first steps 
in the analytics and inspired me to work on the natural products. He was always willing to 
help with his experience and supported me with tips and analytical tricks throughout my 
research. 
 
My sincere thanks are due to Prof. Dr. Samo Kreft of the Faculty of Pharmacy, University of 
Ljubljana, Slovenia, who helped me start my research at the University of Regensburg by 
tutoring my diploma thesis. With his unique and amazing way to inspire people, Prof. Kreft 
was the reason for me to participate in Erasmus exchange program, which opened the door for 
me at the University of Regensburg in the first place. 
 
ACKNOWLEDGEMENTS 
 II 
I would like to thank all my current and ex-colleagues for providing a stimulating and fun 
environment. Special thanks go to Mrs Gabi Brunner, for being a great lab mate and for 
performing the cell counting cytotoxicity assays.  
Furthermore, I must thank colleagues and friends, whose support and colleagueship meant a 
lot, especially: Dr. Tobias Brem, Dr. Stefan Jenning, Dr. Susann Haase, Dr. Birgit Kraus, 
Anne Freischmidt, Susanne Knuth, Katharina Zenger, Rosmarie Scherübl, Magdalena Motyl, 
Dr. Sarah Sutor, Anne Grashuber, Irena Brunskole, Sebastian Schmidt, Daniel Bücherl, 
Marcel Flemming, Thomas Reintjes and my fitness partner Matthias Henke.    
I would also like to thank our trainees Sara Samiei and Matthias Hautmann for supporting me 
during the fractionation and isolation process. Help of following students must also be 
acknowledged: Amelie Bindl, Stephanie Nolde, Sarah Barthold and Eva Tavčar. 
 
I also warmly thank Allan Patrick Macabeo for always being a good colleague and 
encouraging me during some long evenings in the lab. 
 
Special thanks go to the Department of Pharmaceutical Biology, Ludwig-Maximilians 
University of Munich and Prof. Dr. Angelika Vollmar for our fruitful cooperation. I would 
like to thank Mrs Elisabeth Willer for testing my isolates in the permeability assay and Dr. 
Robert Fürst for interresting discussions about the results. 
 
The Department of Pharmaceutical and Medicinal Chemistry, University of Regensburg and 
Prof. Dr. Armin Buschauer are acknowledged for offering us cooperation concerning capillary 
electrophoresis. I am indebted to Mr Martin Rothenhöfer for performing the analysis of the 
absolute stereochemistry of the sugars from compounds isolated during this work. I am 
sincerely grateful for his patience and long hours spent on the CE analysis of my samples. I 
would also like to thank him and Prof. Dr. Günther Bernhardt for fruitful discussions about 
capillary electrophoresis. 
 
Thanks are given to Dr. Edwin Ades, Mr. Fransisco J. Candal of CDC (USA) and Dr. Thomas 
Lawley of Emory University (USA) for providing us with the HMEC-1 cells.  
 
I am also grateful to the NMR department at the University of Regensburg for the 
measurements of the diverse NMR experiment. Special thanks go to Dr. Thomas 
Burgemeister and Mr Fritz Kastner for the help on interpretation of the spectra. 
 
For the measurements of all MS experiments, I wish to thank the MS department of the NWF 
IV (University of Regensburg). I warmly thank Mr Josef Kiermaier, for his patience and 
excellent discussions about MS analysis. 
 
I thank Deutscher Akademischer Austausch Dienst (DAAD) for the financial support and for 
the trust in me and my research. 
ACKNOWLEDGEMENTS 
 III 
 
 
 
To my beloved wife... 
My beautiful wife Mira has always offered me the support that I needed to complete this 
thesis during the last couple of years. In good times and in bad, she stood by my side and gave 
me the reason to continue. Mira, you showed me what it means to love and to be loved, I am a 
better person with you on my side. I thank you for your faithful patience and all the wonderful 
moments shared together, I thank you for being who you are. 
 
 
...and family 
I would also like to thank my mother-in-law, Bonka and brother-in-law, Plamen, for the time 
spent together and all the support from your side. 
 
Alja, I also thank you for being such a nice sister, who always believed in me and loved me 
the way I am. 
 
I thank my aunt Helena for supplying me with energy and motivation during my whole 
schooling. 
   
Last, but not least, my grandmother Milena, my aunt Tejka, and especially my parents, Mirja 
and Rajko, receive my deepest gratitude and love for their dedication and trust in me. You 
showed me the importance of education and helped me find the right way on every step of my 
life. In my eyes, you have always been the ones to turn to and made me proud to have a 
family like you. For your love and endless support, I am dedicating this thesis to you.  
I would also like to dedicate this work to Mira's father Janko, who deceased in the late spring 
of 2008. 
 
 
 
 
 
 
 
Matej Barbič 
Regensburg, 02 March 2011 
ABBREVIATIONS 
 IV 
Abbreviations 
 
13C    Carbon isotope measured in NMR  
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ACN    Acetonitrile 
approx.   approximately 
CAM   Cell Adhesion Molecules 
CC    Column Chromatography 
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COSY   Correlation Spectroscopy 
CV    Crystal Violet 
CVD    Chronic Vascular Disease 
CVI    Chronic Venous Insufficiency 
DCM   Dichloromethane 
ECGM   Endothelial Cell Growth Medium 
EDTA   Ethylenediaminetetraacetic acid 
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EtOAc   Ethyl acetate 
EtOH   Ethanol  
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HPLC   High Performance Liquid Chromatography 
HSQC   Heteronuclear Single Quantum Coherence 
ICAM-1   Inter-Cellular Adhesion Molecule 1 
MeOH   Methanol 
MeOD   Deuterated methanol 
med.    medium 
min    minutes  
MPLC   Medium Pressure Liquid Chromatography 
MS    Mass spectrometry 
MTT    3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromid 
n-BuOH   1-butanol 
NMR   Nuclear Magnetic Resonance 
p.    page number 
Pyr d5   Deuterated pyridine 
ROESY   Rotating frame Overhause Effect Spectroscopy 
rpm    revolutions per minute 
SD    standard deviation 
SDS    sodium dodecyl sulfate 
SE    standard error  
sol.    solution  
TLC    Thin Layer Chromatography 
VCAM-1    Vascular Cell Adhesion Molecule 1 
VLC    Vacuum Liquid Chromatography 
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1 Introduction 
1.1 Ruscus aculeatus L. 
Ruscus aculeatus L., also known as Butcher’s Broom, Kneeholy, Jew's Myrtle or 
Sweet Broom, belongs to the family Ruscaceae (Ziegler et al.: Strasburger - Lehrbuch 
der Botanik für Hochschulen), but is sometimes classified also in the families of 
Liliaceae, Asparagaceae or Convallariaceae. R. aculeatus is a low evergreen plant and 
can also be described as a shrub due to its appearance. Green flat sprouts, ending with 
a spine, are also known as phylloclades and must not be confused with leaves. They 
are the main photosynthetic organs of the plant. Butcher's Broom is a dioecious plant 
and has therefore unisexual flowers (Fig. 1.1 and 1.2, p. 2). They both appear in 
spring and are placed in the middle of the phylloclades. It has been found that R. 
aculeatus has a relatively long flowering season, lasting for approx. seven months. 
Female flowers develop fleshy fruits with 1-4 large seeds and can be observed as red 
berries on the top of the phylloclades (Fig. 1.3, p. 3). Beside seed distribution, 
Butcher's Broom also spreads vegetatively. It has been noted that several species 
recovered after fires. The plant occurs in Mediterranean space and is frequently found 
in woods and bushes. Natural habitats of Butcher's Broom can be found in the South- 
and West-Central Europe, Asia Minor, Northern Africa and Caucasus (Martinez-Palle 
& Aronne 1999, Frohne 2002, Wichtl 2002, Ziegler et al. 2002, Schönfelder 2004, 
Hänsel & Sticher 2007). 
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Fig. 1.1: Ruscus aculeatus, phylloclades with female flowers* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2: Ruscus aculeatus, phylloclade with male flower* 
 
 
 
 
 
* - source: http://www2.arnes.si/~bzwitt/flora/ruscus_aculeatus.html 
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Fig. 1.3: Ruscus aculeatus L., 1, 2, 3 - Rusci flos, 4 - Rusci fructus, A - Rusci 
rhizoma, B - Rusci herba* 
 
 
 
 
 
 
 
* - source: 
 http://commons.wikimedia.org/wiki/File:Illustration_Ruscus_aculeatus0.jpg 
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1.2 Constituents of Ruscus aculeatus 
The steroidal saponins as main ingredients of Butcher's Broom can be divided into 
two major groups: spirostanols (ruscogenin- and neoruscogenin-type) and furostanols 
(ruscoside-type, Fig. 1.4, p. 5). Major differences between saponins of the same type 
lie in the structure of the sugar part at C-1, where several acetylated, sulphated and 
other derivatives have been reported so far (Mimaki et al. 1998 a/b/c, 1999, 2003, 
2008). The OH-goup at C-3 is normally not glycosidated. Furostanol-type saponins 
are stable only with a glucose attached to the terminal C-26 atom of the aglycone, 
which prevents the generation of a full ketal between C-22 and C-26. When the 
glucose is detached, furostanols automatically turn into energy favourable 
spirostanols. Mimaki et al. (1998 a and b) isolated both, C-22 hydroxylated and 
methoxylated furostanol derivatives. So far, it is not clear whether one of the both 
derivatives is an isolation artefact. 
Other constituents have also been isolated, including steroid sapogenines, sterols, 
flavonoids, coumarines, alkaloids (spartein), benzofurans (euparon), thyramine and 
glycolic acid (El Sohly et al. 1975). Although the aerial parts and the rhizomes 
contain saponins, the concentration of these compounds is much higher in the 
rhizomes, the part of the plant traditionally used for treatment of several deseases. 
 
European Pharmacopoeia describes rhizomes from Butcher's Broom (Rusci rhizoma), 
including analysis of its identity and purity as well as quantification of the saponins. 
Percentage of all saponins requires minimally 1% calculated for ruscogenins 
(neoruscogenin and ruscogenin, European Pharmacopoeia 5.3).  
 
Medical use of Butcher's Broom was first mentioned back in the Antique Greece, 
when the rhizomes were administrated for the treatment of inflammations and also 
used as a diuretic laxative as the treatment for hemorrhoids and urinary disorders. 
The most studied therapeutic indications of R. aculeatus nowadays are: venous 
insufficiency, edema, premenstrual syndrome and hemorrhoids. In clinical studies, 
patients were normally treated with 72 to 75 mg of Butcher's Broom extract (methanol 
60%, daily application for 12 weeks, Escop, Vanscheidt et al. 2002, Mackay 2001). 
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A 
B 
C 
Fig. 1.4: Basic spirostanols: A – neuruscogenin (aglycone), B – ruscogenin 
(aglycone), Basic furostanol: C – ruscoside 
R = 
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1.3 Pharmacological properties of extracts and compounds from Ruscus 
aculeatus 
1.3.1 In vitro experiments 
1.3.1.1 Vasoconstriction 
It has been shown that Butcher's Broom extracts (methanol) induce dose-dependent 
contractions (0.001-1 mg/ml) of the rings from saphenous vein removed from female rabbits 
and ensure valvular closure when the veins are exposed to the inversed blood flow 
(Lauressergues et al. 1984, Harker et al. 1988). Further studies including experiments on 
human veins have been performed to show the effects of the extracts on vein contraction. 
After inducing the contraction, maximal vein tonus induced by Butcher's Broom extracts 
(concentration range 0.001-1 mg/mL) was reduced or completely eliminated by blocking α- 
and β-adrenergic receptors with prazosin, rauwolscine or propranolol. This suggests 
sympathomimetic effects of the extracts (Marcelon et al. 1983 and 1988, Rubany et al. 1984, 
Miller et al. 2000).  
 
1.3.1.2 Permeability 
Veins isolated from pig ear were damaged by ethacrynic acid. Pre-incubation with Butcher's 
Broom extracts reduced permeability of water and proteins (Hönig et al. 1989). 
 
Other effects, such as vasoprotection, effect on lymphatic vessels and elastase activity, as one 
of the possible anti-inflammatory mechanisms according to Benedek et al. 2007, have also 
been reported (Escop, Facino et al. 1995). Huang et al. 2008 showed anti-inflammatory 
effects of ruscogenin in vitro (ICAM-1 expression, NF-κB activation, 0.01-1 µM). 
 
1.3.2 In vivo experiments 
1.3.2.1 Vasoconstriction 
Methanolic extracts from Butcher's Broom have been tested for influence on extracorporal 
circulation of anaesthetized dogs. Results showed that treatment with the extract caused a 
reversible increase of the venous pressure (Escop).  
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Assays on hamster cheek pouch have also been performed. When applied topically, a 
temperature dependent vasoconstrictive effect was found (0.01-0.05 mg/mL). At higher 
temperatures constriction was higher than at lower. Intravenous administration also showed 
increase in venular constriction. Oral application (150 g/kg body weight) of a solution of 
Butcher's Broom extract (methanol) for 28 days gave a 30% increase of constriction of the 
venules (Bouskela et al. 1991). 
1.3.2.2 Permeability 
Topical (0.002-2 mg/ml/min) and intravenous (5 mg/kg body weight) application of Butcher's 
Broom extracts to male hamster showed decreased permeability in hamster cheek pouch 
stimulated by permeability-inducing substances such as histamine or bradykinin (Bouskela et 
al. 1994). 
 
1.3.3 Clinical studies 
Several double-blind, placebo-controlled studies have been performed on humans suffering 
from chronic venous disease, such as chronic venous insufficiency and hemorrhoids. Studies 
have shown that R. aculeatus extracts remarkably improve the symptoms of such venous 
diseases (Escop). 
Double blind and placebo controlled studies indicated an improvement of the typical 
symptoms caused by CVI. These manifestations, such as increased ankle diameter, tensions in 
the legs, cramps and edema clearly improved after administration of extracts (72-75 mg, 
methanol 60%, daily application for 12 weeks) from R. aculeatus. It was shown that the 
treatment with Butcher's Broom also reduces the venous diameter and causes significant 
reduction of leg volumes and circumference of the legs and ankles. Other symptoms, such as 
tiredness and heaviness of the legs, have also improved after 12 weeks of treatment with 
extracts from Rusci rhizoma. A final decision, suggesting that extracts from R. aculeatus are a 
safe and effective treatment for cases of chronic venous insufficiency, has been concluded 
(Vanscheidt et al. 2002).  
According to the studies on patients with CVI, it is obvious that extracts from Butcher's 
Broom significantly diminish development of the disease. Therefore a therapy with products 
from R. aculeatus has to be taken into consideration as a treatment. Other studies showed that 
treatment of CVI is a domain of natural products and plant extracts (Beltramino et al. 2000, 
Methlie & Schjøtt 2009, Monsieur & Van Snick 2006). 
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1.3.4 Pharmacokinetics 
In animals, radio-labelled extracts from Butcher's Broom were administrated orally to 
determine the presence of compounds in blood. Radioactivity was measured in different 
periods of time for 24 hours. Constituents from the extract were eliminated in the feces, 
renally and biliary (Escop).  
In humans, R. aculeatus extracts were applied orally and concentration of spirostanol 
saponins in blood was measured using HPLC. It has been proven that spirostanol saponins 
enter blood after an oral administration of 1 g of Butcher's Broom extract. The study showed 
tmax for deglucoruscin between 90-120 min and Cmax of 2.5 µg/mL (Rauwald et al. 1991). 
 
1.4 Chronic Venous Insufficiency (CVI) - pathophysiology and treatment 
Venous pathology can be described as condition when pressure in veins is increased and the 
return of blood to the heart is disturbed. There are several known mechanisms, which are 
believed to be responsible for such conditions. Two main reasons for blood reflux are valvular 
incompetence and venous obstruction. These factors lead to a state called venous 
hypertension, which can be accompanied by edema and eventually lead to primary CVI. 
Changes in the venous pressure also contribute to the microcirculatory hemodynamic 
disturbances which result, when not treated, in dermal changes like hyperpigmentation, tissue 
fibrosis and in later stages ulcerations (Fig. 1.5, p. 9, Eberhardt et al. 2005). 
There are several non- and invasive methods which are used in diagnosis of CVI and can help 
to determine the early stage of desease. The most common and conservative treatment of CVI 
involves measures to reduce symptoms and help prevent the development of secondary 
complications and the progression of the desease. If the measures such as elevating legs and 
the use of compressive stockings fail to provide an apropriate response, further treatment 
based on anatomic and pathophysilogical features is considered. These involve combination 
of several surgical procedures and special excercise programs based on individuals (Eberhardt 
et al. 2005). 
For better understanding of the pathophysiology of chronic vascular deseases (CVDs) such as 
CVI, several experiments on the vascular system of patients with CVI have been performed. It 
has been proven that valves and veins removed from patients with CVI show various signs of 
inflammation. Infiltration of monocytes and macrophages in the valves and venous wall has 
been spotted together with enhanced expression of intercellular adhesion molecule-1 (ICAM-
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1). Furthermore, in patients suffering from CVI, circulating leukocytes also showed higher 
levels of activation. All these facts suggest that inflammation may be a cause and not only a 
consequence of CVI (Bergan 2007, Bergan et al. 2008).  
Advances in the understanding of pathophysiology have shown how molecular mechanisms 
of the inflammation cascade are involved in these findings. It has been shown that leukocytes 
accumulate in the lower extremities, when veins are exposed to hypertension. The reason for 
that are most probably increased leukocyte adhesion on the endothelium and migration 
through the endothelium of small vessels. A release of plasminogen activator has also been 
proven, which indicates leukocyte activation. All the inflammatory hallmarks, like leukocyte 
activation, adhesion and migration suggest that inflammatory plays a key role in the 
pathogenesis of CVI (Bergan 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.5: Manifestations of CVI: A - Uncomplicated varicose veins. B - Hyperpigmentation, 
dermatitis, and severe edema. C - Active and healed venous ulcerations. * - source: see 
Eberhardt 2005 
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1.5 Inflammation and role of the endothelium activation 
The main role of the endothelium is its function as a barrier. It is particularly important for 
regulation of the passage of several molecules and fluids between blood and tissue. Especially 
proteins and other high-weight molecules are restricted to enter the tissue. Transmigration of 
cells is also one of the main parameters that is regulated by the endothelium (Aird 2008, Pries 
et al. 2000, Pasyk & Jakobczak 2004). 
Loss of this function is normally followed by tissue inflammation and plays hereby a major 
role in inflammation-induced diseases. Molecules such as thrombin, bradykinin and histamine 
have a great influence on endothelium and cause disruption of the barrier by disturbing the 
organization of endothelial junctions (Hansson 2009, Sprague & Khalil 2009). 
 
Constant activation of endothelium, caused by chronic inflammation, is an important 
parameter in development of CVDs and could also be responsible for the progression of CVI. 
Two most important hallmarks of the endothelial activation are expression of endothelial cell 
adhesion molecules (CAMs), such as ICAM-1 and VCAM-1, and endothelial 
hyperpermeability (EHP). Inflitration of leukocytes into the tissue during initiation of the 
inflammatory response contributes to the progression of the CVD. The increase in EHP is 
normally followed by edema formation and tissue damage (Weis 2008).  
Expression of adhesion molecules on the surface of the endothelial cells is crucial for 
transmigration of leukocytes into tissue surrounding the blood vessels. Furthermore, the 
increased expression promotes inflammatory process and hereby leads to progression of 
CVDs. CVD itself leads to further endothelium activation via higher CAM expression and 
EHP, which closes this vicious circle. If not treated, CVDs in the long-term lead to 
complications, which most certainly lower quality of life. Untreated CVI patients suffer from 
skin changes, varicose veins and in worst case scenario tissue necrosis and ulcerations (Fig. 
1.5, p. 9). 
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1.6 Aim of the study 
Several studies have proven that extracts produced from R. aculeatus are effective in the 
treatment of CVI (see CVI and treatment, p. 8). It has been shown that steroidal saponins from 
Butcher's Broom can reach bloodstream when applied oraly as an extract (Rauwald et al. 
1991). This fact and the high amount of steroidal saponins in the plant, suggest that the 
positive effect on the CVI is due to the saponins. On the other hand there are no reports 
indicating which compounds contribute to the overall efficacy of Butcher´s Broom 
preparations.  
 
Aim of the present work was to isolate saponins and phenolic compounds from Rusci rhizoma 
and to elucidate their structure. If possible, new compounds from the underground part of 
Butcher's Broom should be found. 
 
It should be investigated, whether furostanol C-22 hydroxylated and methoxylated derivatives 
are both genuine natural products of the plant or if one of them is only an isolation artefact.  
 
The isolated compounds should be tested in vitro to determine their:  
1. influence on the TNF-α induced expression of ICAM-1  
2. influence on the thrombin induced hyperpermeability of endothelial cells. 
 
If possible, a structure-activity-relationship should be described. 
 
These results would broaden the knowledge about the genuine ingredients of Rusci rhizoma 
and their possible contribution to the efficacy of the plant in the treatment of chronic venous 
diseases, such as CVI. 
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2 Materials and Methods 
2.1 Materials for chromatography, spectroscopy and spectrometry 
2.1.1 Plant material 
Rhizomes from Butcher's Broom (Rusci rhizoma, dry, 1 kg) were acquired from Caelo 
(Caesar & Loretz GmbH, Batch Nr.: 40088474) 
 
2.1.2 Solvents and chemicals used for chromatography 
 1-Butanol, for analysis, Sigma-Aldrich 
 Acetic acid (100%), anhydrous, for analysis, Merck 
 Acetonitrile, gradient grade for liquid chromatography, Merck  
 Anisaldehyde (98%), Aldrich 
 Dichloromethane, for analysis, Acros Organics 
 Ethanol (99%), absolute, for analysis, Baker 
 Methanol, for analysis, Merck 
 Methanol, gradient grade for liquid chromatography, Merck 
 Methanol, Uvasol, Merck 
 Sulfuric acid (95-97%), for analysis, Merck 
 Water, deionised 
 Water, drinking 
 
2.1.3 Spray reagents 
 Anisaldehyde reagent: 
− Anisaldehyde  0.5 mL 
− MeOH   85 mL 
− Acetic acid (95%) 10 mL  
− Sulfuric acid (conc.) 5 mL 
 
 20% Sulfuric acid (conc., in MeOH) 
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 Naturstoffreagenz A: 
− 2 g diphenylboryloxyethylamine 
− 200 mL MeOH 
+   
− 10 g polyethyleneglycol 400 
− 200 mL MeOH 
 
2.1.4 Stationary phases for CC, VLC or Flash 
 Silica gel 60 (0.063-0.200 mm) for column chromatography, Merck 
 Silica gel 60 (0.040-0.063 mm) for column chromatography, Merck 
 LiChroprep RP-18 (0.025-0.040 mm) for column chromatography, Merck  
 Sephadex LH-20®, Sigma-Aldrich 
 
2.1.5 Columns used in chromatography 
 Normal glass columns with stopcock for CC 
 VLC glass columns without stopcock modified for application of vacuum 
 Plastic pre-packed columns for flash, Silica 60 (0.015-0.040 mm), 30 g, Merck 
Chimie SAS (all flash columns) 
 Plastic pre-packed columns for flash, Silica 60 (0.015-0.040 mm), 90 g 
 Plastic pre-packed columns for flash, RP-18 (0.015-0.040 mm) 30 g 
 Plastic columns for flash for self-packing, 30 g 
 Plastic columns for flash for self-packing, 90 g 
 HPLC semi-preparative column, RP-18 (7 µm), 2 cm x 25 cm, Knauer 
 HPLC analytical column, RP-18 (5 µm), 0.46 x 25 cm, Purospher STAR, 
Merck 
 LC-MS HPLC column, Gemini NX 3U C18, 10 cm x 0.2 cm, Phenomenex 
 
2.1.6 Other materials 
 TLC Silica gel 60 F256 aluminium sheets, Merck 
 TLC Silica gel 60 RP-18 F256s, Merck 
 TLC chambers 10x10 cm, Camag (small chambers) 
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 TLC chambers 20x20 cm, Camag (big chambers) 
 TLC spotting capillaries, 5 µl, Brand 
 Folin-Ciocalteu reagent, Fluka 
 
2.1.7 NMR materials 
 Pyridine-d5 (99.5%), Deutero 
 Methanol-d4 (99.8%), Deutero 
 NMR tubes 507-HP, Norell 
 
2.1.8 CE Materials 
 D-Glucose, Sigma-Aldrich 
 L-Glucose, Roth 
 D-Arabinose, Sigma-Aldrich 
 L-Arabinose, Sigma-Aldrich 
 D-Galactose, Merck 
 L-Galactose, Sigma-Aldrich 
 L-Rhamnose, Sigma-Aldrich 
 Sodium cyanoborohydride, Sigma-Aldrich 
 S-(-)-1-Phenylethyamin, Sigma-Aldrich 
 Sodium borate, Sigma-Aldrich 
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2.2 Cell culture materials  
2.2.1  Cells and media 
 HMEC-1 cells 
 Endothelial Cell Growth Medium with Supplement and Antibiotics, Provitro 
 Medium 199, PAN GmbH 
 Buffer PBS Dulbecco, w/o Mg2+, Ca2+, Biochrom AG 
 Collagen G, Biochrom AG 
 Fetal Calf Serum (FCS), Biochrom AG 
 Trypsin/EDTA in (10x) PBS, w/o Mg2+, Ca2+, Biochrom AG 
 ICAM-1, FITC labelled antibodies, Biozol 
 TNF-α, Sigma Aldrich 
 MTT, Sigma Aldrich 
 Crystal violet (CV), Merck 
 Trypan blue, Sigma-Aldrich 
 FITC-labelled dextran, Sigma Aldrich 
 SDS, Merck 
 
 
2.2.2 Ready-to-use media 
 Storage Amount 
Cells:  HMEC-1 -196 °C  
 
Growth med.: ECGM 4 °C 500 mL 
 Supplement -20 °C 23.5 mL 
 Antibiotics -20 °C 3.5 mL 
 FCS (inactivated)  -20 °C 50 mL 
 
Stop med.: Medium 199 4 °C 500 mL 
 FCS (inactivated)  -20 °C 50 mL 
 
Coating sol.: PBS 4 °C 500 mL 
 Collagen G (Biochrom, 4 mg/mL) 4 °C 1.25 mL 
 
Trypsin/EDTA: Trypsin/EDTA in PBS -20 °C 100 mL  
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2.2.3 Other 
 Cell cultivation bottles, 75 cm2, TPP 
 96-well plates, TPP 
 24-well plates, TPP 
 Disposable pipettes, Sarstedt 
 12-well Transwell® plate inserts, Corning 
 
 
2.3 List of equipment 
 
2.3.1 General 
Analytical scales Sartorius 
Ultrasonic bath  Sonorex, Bandelin 
Rotary vacuum evaporator Laborota 4003, Heidolph 
Freeze Dryer Ilvac Pia 100, Pietkowski 
UV lamp, 254/366 nm Camag 
 
2.3.2 Spectroscopy and other 
UV spectroscopy Cary 50 Scan, Varian 
Optical rotation Unipol L1000, Schmidt & Haensch 
NMR spectrometers Avance 300, Bruker 
 Avance 600, Bruker 
 Avance III 600 kryo, Bruker 
MS spectrometers EI-MS: Finnigan MAT 95 
 ESI, LC-MS: ThermoQuest Finnigan 
 TSQ 7000 
HPLC preparative Pro Star 210 (pump system with 
 detector), Model 410 autosampler 
 Model 701 fraction collector, Varian 
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HPLC analytical L-2130 pump system, L-2455 
 detector, L2350 column oven,  
 VWR Hitachi 
Flash Armen Instrument 
Capillary electrophoresis Biofocus 3000, Bio Rad 
TLC scanner Reprostar 3, Camag 
Speed extractor  E-916, Büchi 
 
 
2.3.3 Cell culture equipment 
Centrifuge Megafuge 1.0 R, Heraeus Sepatech 
Laminar air flow Clan Laf, Claus Damm 
Incubator New Brunswick Scientific 
Plate reader SpectraFluor plus,Tecan 
Vortex Bender & Hobein AG 
Pipettes Eppendorf 
Neubauer cell counting chamber Brand 
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2.4 Methods used in chromatography, spectroscopy and spectrometry 
2.4.1 Column Chromatography (CC) 
Normal glass columns with stopcock were used to perform chromatography. Stationary 
phases (p. 13) were applied as a suspension in the starting solvent mixture used for the 
elution, using a ratio of solvent/silica = 2 mL/1 g). After sedimentation of the stationary 
phase, the rest of the solvent was emerged from the column. As the level of the solvent 
reached the stationary phase, the flow was stopped to prevent drying of the material.  
Samples (extracts, fractions) dissolved in starting solvent mixture were applied to the 
column. The amount of stationary phase was determined by the weight of the sample. A 
ratio of 1 g sample per 150 g silica was used under condition that the minimum column 
length (~ 20 cm) was reached. The height of the sample applied to the column was not 
higher than ~ 2 mm (1% of the minimum column length). The speed of elution was 
determined by the type of stopcock, varying between 2 and 3 mL/min. 
The fractionation started after the first 80% of the column volume was eluted.  
Methods used were: 
 
CC 1 
Column: Normal glass column with stopcock, Ø = 3 cm, Silica 60 (~ 45 g) 
Fractions: ~ 9 mL 
Solvent system:  
− 100 mL DCM:MeOH = 90:10 
− 200 mL DCM:MeOH = 85:15 
− 600 mL DCM:MeOH = 80:20 
 
CC 2 
Column: Normal glass column with stopcock, Ø = 3 cm, Silica 60 (~ 75 g) 
Fractions: ~ 9 mL 
Solvent system:  
− 600 mL DCM:MeOH = 80:20 
− 1100 mL DCM:MeOH = 75:25 
− 200 mL DCM:MeOH = 70:30 
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CC 3 
Column: Normal glass column with stopcock, Ø = 3 cm, Silica 60 (~ 75 g) 
Fractions: ~ 9 mL 
Solvent system:  
− 1300 mL DCM:MeOH = 80:20 
− 900 mL DCM:MeOH = 75:25 
− 300 mL DCM:MeOH = 70:30 
 
CC 4 
Column: Normal glass column with stopcock, Ø = 2 cm, Silica 60 (~ 50 g) 
Fractions: ~ 9 mL 
Solvent system:  
− 500 mL DCM:MeOH = 90:10 
− 500 mL DCM:MeOH = 80:20 
− 500 mL DCM:MeOH = 70:30 
 
CC 5 
 
Column: Normal glass column with stopcock, Ø = 1.8 cm, RP-18 (~ 20 g) 
Fractions: ~ 9 mL 
Solvent system:  
− 200 mL MeOH:H2O = 20:80 
 
CC 6 
Column: Normal glass column with stopcock, Ø = 2.1 cm, RP-18 (~ 40 g) 
Fractions: ~ 9 mL 
Solvent system:  
− 400 mL MeOH:H2O = 50:50 
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2.4.2 Vacuum Liquid Chromatography (VLC) 
Normal glass columns without stopcock were modified such that vacuum (water pump) 
could have been applied to the chromatographic system. Columns were packed with dry 
materials (silica gel, RP-18 silica). Before the samples were applied, the columns were 
washed with the starting solvent mixture under vacuum. 
Sample (extracts, fractions) was pre-adsorbed on a small amount of silica and applied 
dry to the column. Sea sand was used to prevent the damage on the sample layer during 
solvent addition.  
Method used: 
 
VLC 1 
Column: Glass column for VLC, Ø = 6 cm, Silica 60 (~ 140 g) 
Collection scheme: 
 
Fraction Solvent system DCM:MeOH 
FR 1 400 mL 100:0 + 400 mL 95:5 
FR 2 2 x 200 mL 90:10 
FR 3 5 x 200 mL 90:10 
FR 4 3 x 200 mL 90:10 
FR 5 4 x 100 mL 90:10 
FR 6 5 x 100 mL 90:10 
FR 7 5 x 200 mL 90:10 
FR 8 9 x 200 mL 90:10 + 200 mL 85:15 
FR 9 6 x 200 mL 85:15 
FR 10 3 x 200 mL 85:15 
FR 11 200 mL 85:15 + 2 x 200 mL 80:20 
FR 12 200 mL 80:20 + 200 mL 70:30 
FR 13 600 mL 60:40 
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2.4.3 Flash Chromatography  
A computer aided Armen Instrument machine equipped with two-pump system, 
UV/VIS detector and a fraction collector was used for preparative analysis and 
purification of samples. Special pre- or self-packed plastic columns (p. 13) were applied 
for the separation, normally using a 30 g column as pre-column and a bigger 90 g 
column as main column. Sample was applied dry and pre-adsorbed on the silica after 
the system had been purged by initial solvent system. These chromatographic systems 
allow flows up to 40 mL/min and a maximum pressure of 7 bar. Maximum pressure is 
limited by plastic columns which can not endure pressures higher than 7 bar. Fractions 
were collected using a fraction collector. 
Methods used: 
 
Flash 1 
Column: 30 g pre-column and 90 g main column; pre-packed Silica 60 (0.015-0.040 
mm) 
Fraction collector: 20 mL/test tube 
Start of collection: 20 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] DCM:MeOH 
0-3 20 100:0 
3-15 20 100:0 → 90:10 
15-23 20 90:10 → 85:15 
23-60 20 85:15 → 65:35 
60-90 20 70:30 → 60:40 
90-140 20 60:40 → 50:50 
 
 
Flash 2 
Column: 30 g pre-column and 90 g main column; self-packed Silica 60 (0.040-0.063 
mm) 
Fraction collector: 20 mL/test tube 
Start of collection: 5 min after start of the method 
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Method: 
 
Time [min] Flow [mL/min] DCM:MeOH 
0-2 20 100:0 → 90:10 
2-4 20 90:10 
5-20 20 80:20 
20-60 20 80:20 → 60:40 
60-90 20 60:40 → 50:50 
90-120 20 50:50 → 40:60 
 
 
Flash 3 
Column: 30 g pre-column; self-packed LiChroprep RP-18 (0.025-0.040 mm) 
Fraction collector: 20 mL/test tube 
Start of collection: 1 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] MeOH:H2O 
0-30 10 60:40 
 
 
Flash 4 
Column: 2x 30 g pre-column; self-packed Silica 60 (0.040-0.063 mm) 
Fraction collector: 10 mL/glass 
Start of collection: 1 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] DCM:MeOH:H2O 
0-15 20 95:5:0.5 
16-30 20 90:10:1 
31-60 20 85:15:1.5 
60-65 20 85:15:1.5 
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Flash 5 
Column: 30 g pre-column; pre-packed Silica 60 (0.015-0.040 mm) 
Fraction collector: 20 mL/test tube 
Start of collection: 1 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] DCM:MeOH:H2O 
0-15 20 90:10:1 
16-30 20 85:15:1.5 
31-50 20 80:20:2 
 
 
Flash 6 
Column: 30 g pre-column; self-packed LiChroprep RP-18 (0.025-0.040 mm) 
Fraction collector: 20 mL/test tube 
Start of collection: 1 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] MeOH:H2O 
0-15 20 80:20 
16-35 20 90:10 
36-65 20 100:0 
 
 
Flash 7 
Column: 2x 30 g pre-column; self-packed LiChroprep RP-18 (0.025-0.040 mm) 
Fraction collector: 15 mL/glass 
Start of collection: 1 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] MeOH:H2O 
0-10 15 20:80 
10.5-25 15 30:70 
25.5-40 15 40:60 
40.5-50 15 50:50 
50-110 15 60:40 
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Flash 8 
Column: 30 g pre-column and 90 g main column; self-packed Silica 60 (0.040-0.063 
mm) 
Fraction collector: 20 mL/test tube 
Start of collection: 10 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] DCM:MeOH:H2O 
0-20 20 90:10:1 
21-30 20 85:15:1.5 
31-50 20 80:20:2 
51-60 20 75:25:2.5 
61-75 20 70:30:3 
76-100 20 60:40:4 
 
 
Flash 9 
Column: 30 g pre-column; self-packed LiChroprep RP-18 (0.025-0.040 mm) 
Fraction collector: 20 mL/test tube 
Start of collection: 1 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] MeOH:H2O 
0-5 20 40:60 
5.5-10 20 50:50 
10.5-20 20 60:40 
20.5-30 20 70:30 
30.5-45 20 80:20 
45.5-50 20 100:0 
 
 
Flash 10 
Column: 30 g pre-column; pre-packed Silica 60 (0.040-0.063 mm) 
Fraction collector: 20 mL/test tube 
Start of collection: 2 min after start of the method 
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Method: 
 
Time [min] Flow [mL/min] DCM:MeOH:H2O 
0-5 20 90:10:1 
5-15 20 90:10:1 → 85:15:1.5 
15-20 20 85:15:1.5 
20.5-25 20 83:17:1.7 
25.5-50 20 80:20:2 
 
 
Flash 11 
Column: 30 g pre-column; pre-packed Silica 60 (0.040-0.063 mm) 
Fraction collector: 20 mL/test tube (10-25 min) 
   10 mL/glass (25-45 min) 
   20 mL/test tube (40-50 min) 
Start of collection: 10 min after start of the method 
Method: 
 
Time [min] Flow [mL/min] DCM:MeOH:H2O 
0-5 20 90:10:1 
5-20 20 90:10:1 → 85:15:1.5 
20.5-25 20 85:15:1.5 
25.5-50 20 80:20:2 
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2.4.4 Semi-preparative High Performance Liquid Chromatography 
Semi-preparative Varian HPLC machine was used for the final purification of some 
samples. Samples were injected manually by a syringe. Pure compounds were collected 
manually by monitoring the chromatogram (190-400 nm). 
 
Column used: RP-18 (p. 13), at room temperature 
Injection volume: 600-800 µL 
Solvents used: MeOH, ACN, H2O (p. 13) 
Methods used: 
 
HPLC 1 
Time [min] Flow [mL/min] H2O:MeOH 
0-5 10 60:40 
6-10 10 50:50 
11-40 10 40:60 
41-45 10 60:40 
 
 
HPLC 2 
Time [min] Flow [mL/min] H2O:MeOH 
0-5 10 50:50 
6-16 10 40:60 
17-20 10 30:70 
21-24 10 0:100 
 
 
HPLC 3 
Time [min] Flow [mL/min] H2O:MeOH 
0-5 10 60:40 
6-10 10 50:50 
11-28 10 40:60 
29-35 10 10:90 
 
 
HPLC 4 
Time [min] Flow [mL/min] H2O:MeOH 
0-5 10 50:50 
6-20 10 40:60 
21-25 10 10:90 
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HPLC 5 
Time [min] Flow [mL/min] H2O:MeOH 
0-5 10 70:30 
6-10 10 65:35 
11-15 10 60:40 
16-20 10 50:50 
21-25 10 40:60 
 
 
HPLC 6 
Time [min] Flow [mL/min] H2O:MeOH 
0-3 10 20:80 
4-8 10 15:85 
9-18 10 10:90 
19-20 10 0:100 
 
 
HPLC 7 
Time [min] Flow [mL/min] H2O:ACN 
0-3 10 45:55 
3.5-7 10 40:60 
7.5-11 10 35:65 
11.5-18 10 30:70 
 
 
HPLC 8 
Time [min] Flow [mL/min] H2O:MeOH 
0-4 10 70:30 
5-9 10 65:35 
10-14 10 60:40 
15-19 10 55:45 
 
 
HPLC 9 
Time [min] Flow [mL/min] H2O:MeOH 
0-4 10 70:30 
4.5-9 10 65:35 
9.5-14 10 60:40 
14.5-19 10 50:50 
19.5-21 10 40:60 
21.5-24 10 90:10 
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HPLC 10 
Time [min] Flow [mL/min] H2O:MeOH 
0-3 10 50:50 
3.5-6 10 45:55 
6.5-9 10 40:60 
9.5-12.5 10 35:65 
13-16 10 20:80 
16.5-19 10 10:90 
 
 
 
2.4.5 Analytical High Performance Liquid Chromatography 
VWR Hitachi analytical machine equipped with autosampler, two-pump system, 
UV/VIS DAD detector, oven and a fraction collector was used for the quantification (p. 
31) of the extracts according to Ph. Eur. (European Pharmacopoeia 5.3). 
Method used: 
 
Quanti 
Time [min] Flow [mL/min] H2O:ACN 
0-25 1.2 40:60 
27-37 1.2 0:100 
39-42 1.2 40:60 
 
 
 
2.4.6 Thin Layer Chromatography (TLC) 
TLC was used for the optimization of solvent systems used in CC, VLC, Flash and 
HPLC as well as for determination of fractions after running a column. In order to 
optimize the solvent system, spots (compounds) should show good separation on the 
TLC plate. For fractionation monitoring, solvent system should be used, separating all 
compounds and distributing it in the chromatogram between 0.2 < Rf < 0.8. For 
optimization of starting solvent system for CC, VLC, Flash and HPLC, compounds with 
the highest Rf values should lie between Rf = 0.2-0.3. Standard TLC solvent mixture 
was DCM:MeOH:H2O = 70:30:3. 
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Samples were applied to the plate (1 cm from the edge for small chambers and 1.5 cm 
for big chambers) using 5 µL spotting capillaries (either into spot or line). After 
developing, the TLC plates were dried with a hair dryer and treated with an appropriate 
spray reagent.  
For visualization of the TLCs, a Camag UV lamp and a Camag TLC scanner (software: 
WinCATS) were used. 
 
2.4.7 Liquid-Liquid Extraction 
Solvent extraction and partitioning was used as a work-up method during the process of 
isolation and purification of the extract. The crude extract and fractions were initially 
dissolved with organic solvent and placed in the separatory funnel. The remaining 
residue was stirred with water and added to the organic solvent. The funnel was closed 
and shaken gently by inverting it several times. Excess internal pressure was released by 
opening the stopcock. After repeating the procedure for at least three times, the 
separatory funnel was set aside to allow the separation of both phases. Compounds were 
separated based on their relative solubility in two immiscible solvents. 
 
2.4.8 NMR spectroscopy 
Samples were dissolved in 600 µL of deuterated solvent and transferred to special NMR 
tubes. (p. 14) If necessary, samples were filtered using Pasteur pipettes and glass wool. 
Tubes were applied to the NMR instruments to obtain one- and two-dimensional spectra 
(1H, 13C, HSQC, HMBC, COSY and ROESY). Measurement parameters are given for 
single compounds in section Results & Discussion (referenced against undeuterated 
solvent).  
Software: Bruker Top Spin 2.1 
 
2.4.9 MS spectrometry 
A very small amount of the testing sample was applied into a small glass tube and given 
for the analysis.  
ES-MS: 70 eV, mass range: 34-800 
ESI-MS: Voltage: 3 kV, capillary T: 250 °C, mass range: 10-2500 
MATERIALS & METHODS 
 30 
2.4.10 UV and optical rotation 
Samples were dissolved in MeOH Uvasol (0.1 mg /100 mL) to measure the optical 
rotations. Compounds for the measurements of UV-absorption maxima (λmax) were also 
dissolved in MeOH Uvasol (0.1 mg /mL). 
 
2.4.11 Absolute stereochemisty of sugars via capillary electrophoresis (CE) 
Derivatization procedure and CE method was perfomed according to (Noe & 
Freissmuth 1995) with some modifications. 
Samples (1 mg) were dissolved in 0.5 mL 23% aqueous TFA and sealed in a 1 mL glass 
tube. After 60 min reaction at 120 °C, the TFA solution was transferred into a pear-
shaped flask using 2 mL of water. TFA was treated with additional water (3 times) and 
completely removed by evaporation on a rotary vacuum evaporator. The remaining 
hydrolysis product and all D- and L- sugar references (1 mg per sample) were 
derivatized with 60 µL of 0.1 M S-(-)-1-phenylethylamin to afford the corresponding 
Schiff base, which was immediately reduced to the corresponding diastereoisomers 
using 22.5 µL of 0.46 M aqueous sodium cyanoborohydride solution.  
10 µL of every derivatized sugar reference solution were mixed to obtain a standard 
solution of all sugar diastereoisomers. To determine the signals of single sugars in the 
electropherogram, a standard diastereoisomer solution was spiked with single 
diastereisomers. In order to determine the sugars in compounds isolated from R. 
aculeatus, the standard diastereoisomer solution was spiked with single derivatized 
compounds. Compounds 8 and 9 were used for the derivatization and determination of 
the absolute stereochemistry. 
The prepared solutions were applied to CE.  
CE system used: 
 
Capillary:  70/75 cm, 50 µm, Quarz 
Buffer:  50 mM Na2B4O7 in 23% aqueous ACN, pH 10.3 
Injection: 3 psi sec 
Voltage: 30 kV 
Detection:  200 nm 
Temperature: 27 °C 
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2.4.12 Quantification 
2.4.12.1 Saponins 
Quantification of the saponins from R. aculeatus was performed according to the Ph. 
Eur. (European Pharmacopoeia 5.3) using method Quanti (p. 28).  
 
2.4.12.2 Phenolics 
Quantification of the phenolic compounds in rhizome from Butcher's Broom was 
performed according to the quantification of phenolic compounds in Tormentillae 
rhizoma (Ph. Eur. 5.3 using specific absorption of 1100, proposed by Glasl 1983).   
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2.4.13 Isolation of compounds from Ruscus aculeatus 
2.4.13.1 Extraction 
Underground parts from Butcher's Broom (dry Rusci rhizoma, 1 kg) were pulverised 
and mixed with sea sand in ratio of 2:1 (rhizome:sea sand). The prepared extraction 
material was filled into glass columns and macerated for 48 h in DCM (500 mL per 
column), followed by two percolations with DCM (2 x 300 mL per column). After 
extraction, the DCM extracts were collected in one round bottom flask. After drying the 
material, the same procedure was repeated with MeOH to get the main extract (250 g). 
MeOH extract and all further fractions were developed on Silica 60 TLC plates (p. 13) 
to check the variety of compounds using chromatographic solvent system 
DCM:MeOH:H2O. Depending on the polarity of the fraction, different mixtures were 
used. A standard TLC solvent mixture was DCM:MeOH:H2O = 70:30:3. After 
development of the plates, anisaldehyde spray reagent (p. 12) was used to visualize the 
compounds. As an alternative spray reagent a standard 20% methanolic sulfuric acid 
solution was used. For better visualization of phenolic compounds the 
Naturstoffreagenz A was used. All chromatograms were also analyzed under UV light 
(254 nm and 366 nm). 
 
2.4.13.2 Fractionation 
In order to separate very polar compounds from saponins, a liquid-liquid extraction (p. 
29) was performed with the MeOH extract. Water was used as the hydrophilic phase 
and n-BuOH as the lipophilic phase. To prevent generation of an emulsion, n-BuOH 
was first saturated with water using separatory funnel. After extracting with n-BuOH 
(5x), the n-BuOH and the water phase were obtained. The separation was monitored via 
TLC (Fig. 3.1, p. 46).  
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2.4.13.3 Sephadex fractionation I 
As the next step of fractionation CC chromatography using Sephadex LH-20® 
(Materials, p. 13) was performed. Glass column (4 x 100 cm) was filled with Sephadex 
(4 x 55 cm) suspended in MeOH. The n-BuOH fraction (3 g) dissolved in 8 mL of 
MeOH was applied to the column and fractions (approx. 9 mL at 3 mL/min) were 
collected after approx. 130 mL had been eluted. The chromatography was repeated 5 
times to obtain 5 x 160 fractions, which were combined to 15 fractions according to the 
TLC (Fig. 2.1, p. 33). 
 
 
 
 
Fig. 2.1: TLC plates of the FR 1-14 from first fractionation with Sephadex (see 
Sephadex fractionation I) DCM:MeOH:H2O = 70:30:3, anisaldehyde reagent, 366 nm  
 
 
2.4.13.4 Sephadex fractionation II 
The n-BuOH (3 g) fraction was dissolved in 8 mL MeOH and applied to the Sephadex 
LH-20® column (see Sephadex fractionation I) and fractions (approx. 9 mL at 3 
mL/min) were collected after 130 mL had been eluted separately. TLC showed that 
around fraction 30 most of the saponins already eluted from the column, whereas most 
of the phenolics started to elute. The rest of the fractions were collected into a round 
bottom flask. At the end of this fractionation, the first fraction, poor on phenolics (PPF) 
and the second one, rich on phenolics (PRF), were obtained. The procedure was 
repeated 10 times to get combined fractions of PPF and PRF.  
 
1        2         3          4         5         6        7         8         9        10       11        12      13     14 
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2.4.13.5 Fractionation of PPF 
Fraction containing most of the saponins from the extract (PPF) was chromatographed 
using flash chromatography. Fraction PPF (2 g) was pre-adsorbed on Silica 60 and 
applied dry to the column. After running Flash 1 (Flash methods, p. 21), 120 fractions 
were collected and combined into 8 fractions according to similarity in the TLC. 
Eventually, columns were washed with MeOH to produce fraction 9. FR 1 (test tube: 1-
28), FR 2 (29-31), FR 3 (32-38), FR 4 (39-41), FR 5 (42-46), FR 6 (47-54), FR 7 (55-
64), FR 8 (65-120), FR 9 (MeOH). 
The procedure was repeated 10 times. (Fig. 2.2, p. 34) 
 
 
 
 
 
Fig. 2.2: TLC plate of the FR 1-8 from first flash chromatography of PPF. (see 
fractionation of PPF) DCM:MeOH:H2O = 70:30:3, anisaldehyde reagent, VIS 
 
 
2.4.13.6 Fractionation of PRF 
Fraction rich on polyphenols (PRF) was chromatographed using flash chromatography. 
Fraction PRF (2.2 g) was pre-adsorbed on LiChroprep RP-18 (0.025-0.040 mm) silica 
and applied dry to the column. After running method Flash 2 (Flash methods, p. 21), 
120 fractions were collected and combined into 10 fractions according to the TLC (Fig. 
2.3 and 2.4, p. 35). 
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Fig. 2.3: TLC plate of the FR 1-4 from flash chromatography of PRF (see fractionation 
of PRF). DCM:MeOH:H2O = 90:10:1, anisaldehyde reagent, VIS 
 
 
 
 
 
 
Fig. 2.4: TLC plate of the FR 5-10 from flash chromatography of PRF (see 
fractionation of PRF). DCM:MeOH:H2O = 80:20:2, anisaldehyde reagent, VIS 
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2.4.13.7 Isolation procedure 
After the first sephadex fractionation (Sephadex fractionation I, p. 33), all fractions 
were freeze dried and weighed. Fraction 3 (~ 4.6 g) was chromatographed on Silica 60 
using a VLC 1 method (VLC methods, p. 20) to get 13 fractions (FR I-XIII). Further 
fractionation of FR VII (~ 242 mg) using CC 1 (CC methods, p. 18) yielded 1 (test 
tubes: 12-47, 25.7 mg). Fraction X (1 g) was separated twice using CC 2 and CC 3. 
Fractionation using CC 2 (~ 500 mg of FR X) gave 2 (test tube: 30-55, 227.5 mg). 
Fractionation using CC 3 (~ 500 mg of FR X) gave 4 (test tubes: 1-8, 3.7 mg). 
Fraction 7 (~ 281 mg) from Sephadex fractionation I (Sephadex fractionation I, p. 33) 
was chromatographed using CC 4 where fraction from test tubes: 78-130 (~ 36 mg) was 
further fractionated using CC 5 to get 10 (test tubes: 7-17, 1.0 mg). 
PPF (2 g) was chromatographed using method Flash 1 to get 120 fractions. They were 
combined similar to Fig. 2.2, p. 34 to get 9 fractions where FR 7 (~ 227 mg) was further 
fractionated via CC 6. Fraction containing test tubes: 10-80 (~ 46 mg) was purified 
using HPLC 1 to yield 3 (10 min, 10.6 mg).  
FR 2 from PPF fractionation (~ 514 mg, Fractionation of PPF, p. 34) was submitted to 
flash using Flash 5 to get 50 fractions, where FR 21-23 were further chromatographed 
using Flash 6 to get 25 fractions. FR 9-25 was submitted to semi-preparative HPLC for 
final purification. HPLC 6 was used to obtain D1 (13 min), D2 (14 min) and D3 (16 
min). Fraction D3 was re-crystallized in ACN to get 6 (13.4 mg). Fraction D2 was 
purified twice via HPLC 7 to afford D2-2 (14.5 min), which was identified as 7 (1.8 
mg).  
FR 5 from PPF fractionation (~ 4.3 g, Fractionation of PRF, p. 34) was submitted to 
flash chromatography using Flash 8 to get almost pure 8 and was finally purified using 
Flash 9 and Flash 10 to get 50 fractions. FR 35-38 was identified as 8 (87.4 mg). FR 
30-32 was purified using Flash 11 to get 9 (11.1 mg).  
FR 6 (~ 87 mg) from PRF fractionation (Fractionation of PRF, p. 34) was purified using 
Flash 3 to get 16 fractions. Further fractionation of FR 11-16 (~ 45 mg) via HPLC 2 
yielded 5 (18 min).  
FR 1 (~ 83 mg) from PRF fractionation (Fractionation of PRF, p. 34) was 
chromatographed using Flash 4 to get 100 fractions. FR 7-24 was submitted to semi-
preparative HPLC using HPLC 3 to get A1 (4.5 min), A2 (9 min), A3 (10 min), A4 (15 
min), A5 (22 min) and A6 (24 min). Due to low weight, the only relevant fraction was 
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A6, which was purified using HPLC 4 to get 11 (19 min, 0.3 mg). FR 25-40 was 
purified using HPLC 3 to get B1 (14.5 min), B2 (18.5 min) and B3 (24 min). B3 was 
also identified as 11 (0.2 mg). 
FR 2 (~ 450 mg) from PRF fractionation (Fractionation of PRF, p. 34) was fractionated 
using Flash 7 to get 100 fractions. FR 14-23 was purified twice using HPLC 5 to get 12 
(6 min, 7.3 mg). FR 48-54 was purified using HPLC 8 and HPLC 9 to get 13 (23 min, 
0.4 mg), which was identified as a mixture of diastereoisomers and was therefore not 
described in the Results & Discussion section. FR 71-78 was purified using HPLC 10 to 
yield 14 (15 min, 1.2 mg). 
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2.4.14 Origin of C-22 hydroxy- and methoxylated compounds 
2.4.14.1 Inert extraction from Butcher's Broom rhizome via speed extractor 
Plant material (rhizome) was first de-fatted with DCM and EtOAc followed by the 
extraction with n-BuOH. For control, a parallel extract was produced with water 
followed by liquid-liquid extraction with n-BuOH. Together, four different samples 
were produced. 
For extraction, Büchi Speed extractor E-916 was used. A mixture of sea sand and 
powdered rhizomes (10:1) was prepared. Special 20 mL steel cartridges were filled with 
10 g of the mixture and placed into the extractor. Automated extraction was performed 
according to the pre-set method. 
 
Speed extractor method used: 
 
Temperature: 850C 
Pressure: 100 bar 
Rinsing with solvent: 2 min 
Rinsing with gas: 3 min 
Number of cycles: 4 
   
 
 
2.4.14.2 LC-MS analysis of the extracts  
HPLC-MS coupled experiments (ESI-MS) on the extracts from speed extractor were 
performed by following methods: 
 
Column: RP-18 (p. 13) 
Methods: 
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MS 1  
Time [min] Flow [mL/min] H2O*:ACN* 
0-20 0.3 97:3 → 2:98 
20-25 0.3 2:98 
25-26 0.3 2:98 → 97:3 
26-30 0.3 97:3 
* - including 1% acetic acid 
 
 
MS 2  
Time [min] Flow [mL/min] H2O*:ACN* 
0-20 0.3 97:3 → 2:98 
20-25 0.3 2:98 
25-26 0.3 2:98 → 97:3 
26-30 0.3 97:3 
* - including 0.1% formic acid 
 
 
MS 3  
Time [min] Flow [mL/min] H2O*:ACN* 
0-30 0.4 90:10 → 60:40 
30-35 0.4 60:40 → 2:98  
35-40 0.4 2:98 
40-41 0.4 2:98 → 90:10 
41-45 0.4 90:10 
* - including 0.1% formic acid 
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2.4.14.3 Time dependent NMR meausurements on C-22 hydroxylated coumpound in 
MeOD 
Compound 3 (p. 57) was dissolved in MeOD and incubated in NMR tube. Possible 
changes during the incubation time were measured on a Bruker Avance III 600 Kryo 
spectrometer. Proton spectrum was measured every day in the first week. After 3 weeks, 
3 months and 6 months further 1H-spectra were recorded. After 6 months, deuterated 
methanol was removed and 3 was dissolved in pyridine-d5 to perform a complete 1 and 
2D spectrum analysis. After removing the pyridine, investigated sample was incubated 
in water for three days. After drying the sample, 1 and 2D NMR analysis in pyridine-d5 
followed.   
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2.5 Cell culture assays and cultivation 
2.5.1 FCS inactivation 
FCS (500 mL bottle) was partially thawed at room temperature and totally thawed at 37 °C. 
Water bath was set to 56 °C. After the temperature in a reference bottle reached 56°C, FCS 
was inactivated for 30 min. So prepared FCS was partitioned into 50 mL falcons and stored at 
-20°C after cooling down. 
 
2.5.2 Coating 
All bottles and plates used for cell cultivation were coated with Collagen G solution for 30 
min before the cells were applied. Volumes used were 10 mL for bottles, 100 µL/well for 96-
well plates and 500 µL/well for 24-well plates. Collagen G is used for better adhesion of the 
cells on the bottom of the cultivation bottles and wells. 
 
2.5.3 Cell splitting and cultivation 
After removing exhausted growth medium from the bottle, cells were carefully washed twice 
with PBS buffer solution. Cells were dissolved by trypsin/EDTA solution for 3 min in 
incubator at 37 °C and 5% CO2. The detachment of cells was checked by microscopy. To stop 
the trypsinization process, stop medium was added. After light shaking, re-suspended cells 
were transferred into a falcon and applied to centrifuge for 5 min at 1000 rpm. Supernatant 
was removed and the cells were re-suspended in fresh growth medium to get the basic cell 
suspension. Depending on the splitting ratio, a small amount of this suspension was diluted in 
growth medium to 25 mL and applied into the pre-coated bottle. Labelled bottles were 
incubated at 37 °C and 5% CO2. 
 
2.5.4 ICAM-1 expression inhibition assay and flow cytometry 
ICAM-1 expression (ICAM-1 assay) was measured according to Dirsch et al. 2004 with some 
modifications. Confluent grown HMEC-1 cells were pre-incubated with test samples 
(dissolved in medium), parthenolide (10 µM in medium; positive control) and only with 
medium (negative control) in 24-well plates (n = 2 for each value). 20 min later TNF-α (10 
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ng/mL) was added into the wells, except for the negative control, to stimulate ICAM-1 
expression. After 24 h cells were removed from the plates, fixed with formalin and washed 
with PBS. FITC-labelled mouse antibodies against ICAM-1 were added in order to detect the 
adhesion molecules. For quantification, the amount of fluorescence was measured by flow 
cytometer - FACS analysis (Becton/Dickinson FACSCalibur with argon laser, FL1 detector, 
excitation: 495 nm, emission: 519 nm, voltage: 500 V, flow: 60 µl/min, gated cells: 5000). 
Flow cytometry allows sorting, counting and analysing of several parameters of single cells 
suspended in a fluid. Cells or parts of the cells are first dyed with a fluorescence dye or 
marked with fluorescence-emitting antibodies, which can then be detected in the cytometer.  
 
2.5.5 Macromolecular permeability assay 
Permeability assay was performed by E. Willer and Dr. Robert Fürst at the LMU in Munich. 
HMECs were seeded on 12-well Transwell® plate inserts (n = 3; collagen G pre-coated, pore 
size 0.4 μm, polyester membrane) and incubated for 48 h. FITC-dextran (40 kDa; 1 mg/mL) 
was added to the upper compartment at t = 0 min. Cells were stimulated with thrombin (3 
U/mL, t = 0 min) after preincubation with compounds. At t = 0, 5, 10, 15 and 30 min, samples 
were taken from the lower compartment. The increase in fluorescence of the samples was 
measured with a SpectraFluor plus plate reader at 560 nm where the mean fluorescence of 
with thrombin stimulated cells at t = 30 min was set as 100% and that of non-stimulated cells 
as 0%. The rest of the data (with compounds stimulated cells) were expressed as the percent 
of fluorescence of the 100% control. The higher the value the higher is also the permeability. 
 
2.5.6 Viability assay 
The MTT viability assay (n = 3) was performed according to Mosmann 1983 with 
modifications. Confluent grown HMEC-1 cells were incubated with test samples in 96-well 
plates (in growth medium; n = 6). Pure growth medium was used as the negative control (n = 
6). After 24 h the substances and the supernatant were removed and 10 µL MTT (5 mg/mL) in 
90 µL medium were added for 3 h. This solution was exchanged for 10% sodium dodecyl 
sulfate (100 µL) and 24 h later the absorbance was measured with a SpectraFluor plus plate 
reader at 560 nm. 
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2.5.7 IC50 value of compound 6 in viability assay 
Confluent grown HMEC-1 cells were incubated with compound 6 at following 
concentrations: 50 µM, 40 µM, 35 µM, 30 µM, 25 µM, 20 µM 15 µM and 10 µM in 96-well 
plates (in growth medium; pure growth medium for negative control; n = 6 for each value). 
Further procedure was equal to the normal MTT assay. IC50 was determined by using a 
logarithmic dose-dependent curve, displayed in Microsoft Excel. 
 
2.5.8 Influence of ruscin and deglucoruscin on the HMEC-1 cell density 
2.5.8.1 Cell staining using CV 
Confluent grown HMEC-1 cells were incubated with 1 (deglucoruscin) and 8 (ruscin), using 
50 µM solutions in 96-well plates (n = 3; in growth medium; pure growth medium for 
negative control; n = 6 for each value). After 24 h, the substances and the supernatant were 
removed and the cells were stained with an ethanolic solution of crystal violet (CV, 0.5% in 
20% MeOH) for 15 min and washed with water. For quantification, the CV was dissolved 
with 100 µL of a 0.1 M ethanolic sodium citrate solution and the absorbance was measured 
with a SpectraFluor plus plate reader (Tecan) at 560 nm. 
 
2.5.8.2 Cell counting assay using Trypan blue (24 well) 
Confluent grown HMEC-1 cells were incubated with 1 and 8 using 50 µM solutions in 24-
well plates (n = 3; in growth medium; pure growth medium for negative control; n = 3 for 
each value). After 24 h, the substances and the supernatant were removed and the cells were 
dissolved by 500 µL trypsin/EDTA (Cell splitting, p. 41). Stop medium (500 µL) was added. 
Resuspended cells were transferred to falcon and applied to centrifuge for 5 min at 1000 rpm. 
The supernatant was removed and the cells were resuspended in 1000 µL fresh growth 
medium to get the base cell suspension. Cell suspension (50 µL) was mixed with trypan blue 
solution and the cells were counted using a Neubauer cell counting chamber. 
 
2.5.8.3 Cell counting assay using Trypan blue (6 well) 
Confluent grown HMEC-1 cells were incubated with 1 and 8 using 50 µM solutions in 6-well 
plates (n = 3; 2000 µL growth medium; pure growth medium for negative control; n = 3 for 
each value). After 24 h the substances and the supernatant were removed and the cells were 
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dissolved by 1000 µL trypsin/EDTA (Cell splitting, p. 41). Stop medium (1000 µL) was 
added and cells were resuspended in fresh growth medium to get 5000 µL of the base cell 
suspension. Cell suspension (50 µL) was mixed with trypan blue solution (50 µL) and the 
cells were counted using a Neubauer cell counting chamber. 
 
2.6 Statistical analysis 
Experiments were performed three times (n = 3) and data were expressed as mean value ± SD 
or SE, as indicated in the figures. Grubbs' test was performed to expunge the outliers. 
Significances towards control values were calculated using Student's t-test (*** p < 0.001, ** 
p < 0.01, * p < 0.05). 
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3 Results and Discussion 
3.1 Isolation and identification of compounds from Ruscus aculeatus 
3.1.1 Fractionation and isolation 
Since Rusci rhizoma is the most common part of Butcher's Broom that has been worked on in 
the past and used for treatment of chronical venous diseases, rhizomes from R. aculeatus 
(Materials & Methods, p. 12) were chosen as starting material for extraction and further 
purification. Most common solvent for extraction from Rusci rhizoma is MeOH, therefore 
initial extract was produced with MeOH after de-fatting the rhizomes with DCM (Extraction, 
p. 32). Extract was characterized by TLC on normal phase silica using solvent system 
DCM:MeOH:H2O = 70:30:3 as the mobile phase. The same system was used for other TLC 
experiments performed during this research, since it gave the best overview of the compound 
spectrum. To derivatize the compounds on TLC plates, anisaldehyde and sulfuric acid spray 
reagents were used. Saponins sprayed with anisaldehyde reagent gave dark green, whereas the 
same compounds sprayed with sulphuric acid gave brown spots. Under UV (366 nm), 
saponins were fluorescent red with both anisaldehyde and sulphuric acid. Anisaldehyde was 
set to be standard spray reagent in this work, as several compounds were able to be visualized 
under UV after derivatization. 
As expected for rhizomes, the MeOH extract contained several sugars, from mono- to 
oligosaccharides. These compounds can disturb further fractionation and are also very 
inconvenient to work with. In order to remove a great part of the saccharides, the MeOH 
extract was partitioned between n-BuOH and water. Most of the very polar compounds were 
successfully removed from the methanolic extract (Fig. 3.1, p. 46). 
According to the TLC and literature, it was clear that butanolic extract contained several 
different saponins. In order to develop a reproducible method for saponin isolation a different 
approach has been chosen. Instead of standard fractionation based on silica column 
chromatography, a method with Sephadex LH-20® was used. Sephadex is a dextran gel cross-
linked with epichlorhydrin and is most frequently used for size exclusion chromatography in 
biochemical procedure. Bigger molecules normally travel through the gel faster as the smaller 
ones. In case of secondary metabolites separation occurs partially also due to the different 
polarity of the compounds and for phenolics due to adsorption effects leading a decelerated 
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elution of aromatic compounds in comparison to non-aromatic ones. Starting sephadex 
fractionation with MeOH (Sephadex fractionation I, p. 33) gave first impressions about the 
separation. Information about other compounds than saponins was also gathered. Most of the 
compounds eluting from the column later than the saponins showed different UV/VIS 
coloration. Derivatization with NSR showed the presence of several phenolic compounds 
which were under UV at 366 nm detected as yellow, orange and blue spots. This suggested 
that the extract contained flavonoid and caffeic acid derivatives. It was possible to develop a 
method (Sephadex fractionation II, p. 33) where only two major fractions were collected: a 
fraction poor on phenolics (PPF) and a fraction rich on phenolics (PRF, Fig. 3.1, p. 46). 
Sephadex fractionation I gave some interesting saponin and phenolic fractions. Due to high 
amount of fractions, only some of them were further chromatographed. Low weight phenolic 
fractions with a very diverse compound spectrum were even more problematic.  
Most common fractionation and purification method of the fractions from the first sephadex 
fractionation was column chromatography (CC, Materials & Methods, p. 18) using a 
combination of normal phase silica and reverse phase RP-18 material. For very raw fractions 
a vacuum liquid chromatography (VLC, Materials & Methods, p. 20) was performed. 
Further fractionation steps were performed by Flash (Materials & Methods p. 21) due to a 
better and more reproducible separation quality as well as massive time and solvent reduction 
compared to CC. Using enough starting material, final purification would also be possible. 
 
 
 
Fig. 3.1: TLC Plate of the MeOH extract (1), n-BuOH phase (2), water phase (3), PPF (4), 
PRF (5) and ruscogenins (6). Silica 60, DCM:MeOH:H2O = 70:30:3, anisaldehyde reagent, 
366 nm 
         1                   2                 3                4                 5               6 
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Most of the final purifications were performed using a semi-preparative HPLC (Materials & 
Methods p. 26). Smaller fractions, such as minor saponin mixtures and low weight phenolic 
fractions were purified with the same chromatographic system. Main problem of the saponin 
isolation is the lacking chromophore resulting in a detection wavelength at around 200 nm. 
Therefore final purifications of the saponins had to be confirmed by TLC and derivatized with 
anisaldehyde reagent. 
Another analytical problem was the structural similarity of different saponins resulting in a 
difficult seperation. On the other hand, the small amount of phenolic compounds also made 
them difficult to isolate. Advantageous in case of phenolic compounds is their existing 
chromophore. All isolation pathways leading to pure compounds are shown in Fig. 3.3, p. 48 
and Fig. 3.4, p. 49.  
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MeOH extract (25% of rhizomes) 
n-BuOH extract (29.7%) H2O extract (57.4%) 
Sephadex fractionation I Sephadex fractionation II 
Sephadex fractionation I 
FR 3 FR 7 
VLC 1 
FR VII FR X 
CC 2 CC 3 CC 1 
Compound 2 Compound 4 Compound 1 
 
CC 4 
FR 78-130 
CC 5 
Compound 10 
 
  
 
 
 
 
 
 
 
Fig. 3.2: Main fractionation pathway of the MeOH extract and yields (mass %, rest of the 
MeOH extract was lost or distributed into emulsion phase between organic and water fraction 
during the liquid-liquid chromatography, Materials & Methods, p. 32). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3: Sephadex fractionation I pathway leading to the isolation of 1, 2, 4 and 10. Methods 
used are marked light green (see Materials & Methods for explanation). 
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Sephadex fractionation II 
PPF (80.3% of n-BuOH) 
PRF (7.5% of n-BuOH) 
Flash 1 
FR 2 FR 5 
Flash 8 Flash 5 
Flash 1 
FR 7 
CC 6 
FR 10-80 
HPLC 1 
Compound 3 
FR 21-23 
Flash 6 
FR 9-25 
HPLC 6 
D2 D3 
Compound 6 HPLC 7 
Compound 7 
impure 8 
Flash 9 + Flash 10 
Compound 8 FR 30-32 
Flash 11 
Compound 9 
Flash 2 
FR 1 FR 2 Fr 6 
Flash 3 
FR 11-16 
HPLC 2 
Compound 5 
Flash 7 
FR 14-23 FR 48-54 FR 71-78 
HPLC 10 
Compound 14 
HPLC 8 + 
HPLC 9 
Compound 13 
HPLC 5 
Compound 12 
Flash 4 
FR 7-24 FR 25-40 
HPLC 3 
B3 = 11 
HPLC 3 
A6 
HPLC 4 
Compound 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.4: Sephadex fractionation II pathway leading to the isolation of 3, 5, 6, 7, 8, 9, 11, 12, 
13 and 14. Methods used are marked light green (see Materials and Methods for explanation). 
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3.1.2 Structure elucidation 
Isolated compounds were submitted for the NMR analysis which is the most common and 
powerful tool for structure elucidation. Beside classical 1H and 13C experiments, also 2D 
measurements were performed. HSQC gave information about 1JH,C correlations, meaning, 
that we were able to determine protons connected directly to a specific carbon. In HMBC 
2JH,C and 3JH,C in some cases also 4JH,C correlations were determined. COSY is a very useful 
experiment where geminal and vicinal protons are detected. It is especially helpful in the 
structure elucidation of saponins due to the presence of several -CH2- and -CH- groups. For 
correlation between protons through space, ROESY experiments were performed. 
As the supporting experiments to the NMR, ESI-MS (electro spray ionisation) spectra were 
measured to get molecular weight of isolated compounds. ESI-MS is a very mild method 
ionisation method meaning that compounds remain intact forming most prominently 
pseudomolecular ions. Occasionally, bigger fragments, such as sugars, can be detached from 
the compound. On the other hand, EI-MS experiments cause ionisation to smaller fragments 
of the compound. Both experiments give helpful information for easier structure elucidation. 
HR-MS (high resolution MS) is a special experiment, where exact mass of compounds can be 
measured. With this method, we can also predict the chemical formula of the compound.  
To get even more information about the compounds, optical rotation and UV spectra were 
measured (Materials & Methods p. 29).  
With the above described methods, it was possible to determine the structures with their 
relative stereochemistry. To determine the absolute stereochemistry of sugars, they were 
detached from the glycoside and transformed into their diastereisomers with S-(-)-1-
phenylethylamine. By comparising with reference sugars, absolute stereochemistry of the 
sugars was determined using CE (Materials & Methods p. 30).  
Detailed information about structure elucidation is described in following chapters. 
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3.1.3 Identification of steroid saponins 
3.1.3.1 Compound 1 (Deglucoruscine) 
 
 
 
 
 
Compound 1 was isolated (25.7 mg) and identified as deglucoruscine (isolation scheme, p. 
32). TLC chromatograms sprayed with anisaldehyde reagent gave typical green coloration 
which was observed as red fluorescence spot under UV at 366 nm (Rf = 0.65 in standard 
system, p. 28). 1H NMR experiment confirmed a saponin structure with characteristic signals 
for the aglycone between approx 1 - 3 ppm and for the sugar moieties at around 3.5 - 5 ppm 
(Table 3.1, p. 53 and Fig 3.5, p.54). Most common signals were the methyl groups of the 
aglycone, H3-18 at δ = 0.84 ppm (s), H3-19 at δ = 1.44 ppm (s) and H3-21 at δ = 1.03 ppm (d). 
In 13C experiment several signals were suggesting a neoruscogenin aglycon. C-27 exo-
methylene group signal was found at δ = 108.7 ppm. Signals at δ = 139.6 ppm, δ = 124.7 ppm 
and δ = 144.5 ppm were typical for C-5, C-6 and C-25. Carbon at δ = 83.6 ppm that showed 
correlation to a proton at δ = 3.83 ppm (dd) in HSQC was identified as C-1 and is also a very 
characteristic signal for neoruscogenin (Mimaki et al. 1998 a/b/c, 1999, 2003, 2008). With 
these signals as a starting point for structure elucidation, aglycone was identified as 
neoruscogenin using COSY and HMBC. Correlations from C-1 to C-4 and C-6 to C-20 
followed by correlations from C-23 to C-24 were observed, meaning, that most of the signals 
were assigned using COSY. Position of quaternary carbons was determined via HMBC. 
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Absolute stereochemistry was confirmed via ROESY, where C-19 was set to β position 
(Hänsel & Sticher). 
Two signals at δ = 100.4 ppm and δ = 101.8 ppm correlating with protons at δ = 4.71 ppm (d) 
- H-1' and δ = 6.34 ppm (d) - H-1'' suggested the presence of two anomeric protons of two 
sugars. With aglycone structure elucidated, remaining unassigned 11 carbons confirmed two 
sugars, a pentose and a hexose. Sugar signals were assigned using COSY and HMBC where 
H-1' was identified as the anomeric proton of the arabinose and H-1'' as the anomeric proton 
of the rhamnose. HMBC correlation between H-1' and C-1 clearly proved that arabinose is 
attached to the aglycone at C-1 (Fig. 3.6, p. 54). Correlation between H-2' and C-1'' signified 
that the rhamnose was attached to the arabinose at C-2' (Fig. 3.7, p. 55).  
Compound 1 showed a pseudomolecular ion peak at m/z: 705 [M-H]- in negative-ion ESI-MS 
which confirmed the proposed structure from NMR analysis.  
Capillary electrophoresis confirmed the presence of L-arabinose and L-rhamnose (Materials 
& Methods p. 30 and CE results p. 101). Normal L-arabinose chair conformation is 4C1. 
Therefore 3JH-1'/H-2' = 7.3 Hz signifies the presence of α-L-arabinose. In the case of β-L-
arabinose a very small 3JH-1'/H-2' value would be observed (Markham 1989). Stable 
conformation of L-rhamnose is a 1C4 chair conformation. Therefore, a small 3JH-1''/H-2'' = 1.0 
Hz value confirmed the presence of α-L-rhamnose. 
The optical rotation of 1 was measured [α] 24D  = -78.3 (c = 0.1, MeOH) and UV maximum at 
202 nm (0.1 mg/mL, ε = 7413 L/mol cm). 
With all these facts gathered, the structure of deglucoruscin was confirmed and identical to 
literature data (Mimaki et al. 1998 b).  
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Nr. C Nr. H 
1 83.6 1 3.83 dd (11.9, 3.9) 
2 37.4 2 2.73 m* 
2.35 q (11.9) 
3 68.2 3 3.87 m* 
4 43.9 4 2.69 m* 
2.57 m 
5 139.6 5  
6 124.7 6 5.57 m 
7 32.0 7 1.87 m* 
1.52 m* 
8 33.2 8 1.56 m* 
9 50.4 9 1.50 m* 
10 42.9 10  
11 24.1 11 2.97 m 
1.62 m* 
12 40.3 12 1.51 m* 
1.26 m* 
13 40.2 13  
14 56.8 14 1.10 m* 
15 32.4 15 1.99 m 
1.42 m* 
16 81.5 16 4.50 m* 
17 63.0 17 1.70 m* 
18 16.7 18 0.84 s 
19 15.1 19 1.44 s 
20 41.8 20 1.90 m* 
21 15.0 21 1.03 d (7.0) 
22 109.5 22  
23 33.2 23 1.74 m* 
24 29.0 24 2.69 m* 
2.22 m 
25 144.5 25  
26 65.0 26 4.44 d (12.1) 
4.00 d (11.9) 
27 108.7 27 4.79 s 
4.75 s 
1’ 100.4 1’ 4.71 d (7.3) 
2’ 75.2 2’ 4.59 t (8.1) 
3’ 76.0 3’ 4.14 m* 
4’ 70.2 4’ 4.14 m* 
5’ 67.4 5’ 4.26 dd (12.4, 0.1) 
3.65 d (12.1) 
1’’ 101.8 1’’ 6.34 d (1.0) 
2’’ 72.6 2’’ 4.73 s broad 
3’’ 72.7 3’’ 4.64 dd (9.2, 2.7) 
4’’ 74.3 4’’ 4.32 t (9.4) 
5’’ 69.5 5’’ 4.85 m 
6’’ 19.1 6’’ 1.74 d (6.2) 
 
Table 3.1: 1H and 13C NMR data for compound 1 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in pyridine d-5, * - overlapping signals) 
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm 
 
Fig. 3.5: 1H spectrum (pyridine d-5, 600 MHz) of 1 with clearly separated areas of sugar and 
aglycone signals.. Solvent signals at 7.2 ppm, 7.6 ppm and 8.7 ppm together with water signal 
in pyridine at 4.9 ppm.  
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Fig. 3.6: HMBC correlation between C-1 (δ = 83.6 ppm) and H-1' (δ = 4.71 ppm) of 1, 
confirming the position of arabinose at C-1 of the aglycone. 
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Fig. 3.7: HMBC correlation between C-2' (δ = 75.2 ppm) and H-1'' (δ = 6.34 ppm) of 1, 
confirming that rhamnose is attached to arabinose at position C-2'. 
3JC-2'/H-1'' 
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3.1.3.2 Compound 2 (22-O-methyldeglucoruscoside) 
 
 
 
 
 
Compound 2 was isolated (227.5 mg) and identified as 22-O methoxylated deglucoruscoside 
(isolation scheme p. 32). Spots on the TLC chromatograms detected with anisaldehyde 
reagent were coloured green and exhibited fluorescence spots at 366 nm, which was typical 
for saponins (Rf = 0.23 in standard system, p. 28). 
1H NMR experiment confirmed a saponin structure with characteristic signals for the 
aglycone between approx 1 - 3 ppm and for the sugar moieties at around 3.5 - 5 ppm. As in all 
steroid saponins isolated from Ruscus, most common signals were the methyl groups of the 
aglycone. With the m/z: 899 [M-H]- in negative-ion ESI-MS and with data from the literature 
(Mimaki et al. 1998 b), we concluded that the isolated compound is 22-O-
methyldeglucoruscoside. Before running the complete 2D NMR analysis, 2 was submitted for 
freeze drying. During the process of freezing in water and drying on the freeze dryer, 2 
decomposed over night into two saponins. Following ESI-MS experiment gave two m/z 
signals, one for original compound at 899 [M-H]- and one at 885 [M-H]-. After investigating 
the structure of 2 and considering Kite et al., final conclusion was that 2 got de-methylated in 
water at the position C-22. 13C and 2D NMR spectra of the mixture were performed, but no 
signal assignments were done due to highly overlapping signals. In order to investigate this 
transformation process, further testing was planned. (Origin of C-22 hydroxylated and 
methoxylated compounds p. 38 and p. 112).  
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3.1.3.3 Compound 3 (Deglucoruscoside) 
 
 
 
 
 
Compound 3 was isolated (10.6 mg) and identified as deglucoruscoside (isolation scheme p. 
32). TLC chromatograms sprayed with anisaldehyde reagent gave typical green coloration 
which was observed as red fluorescence spot under UV at 366 nm (Rf = 0.18 in standard 
system, p. 28). 
1H NMR experiment confirmed a saponin structure with characteristic signals for the 
aglycone between approx. 1 - 3 ppm and for the sugar moieties at around 3.5 - 5 ppm (Table 
3.2, p. 59 and Fig 3.8, p. 60). Typical signals, such as methyl groups of the aglycone, H3-18 at 
δ = 0.90 ppm (s), H3-19 at δ = 1.44 ppm (s) and H3-21 at δ = 1.26 ppm (d) were found. 
Similar to 1, several signals in 13C experiment also suggested the presence of a neoruscogenin 
aglycon. C-27 exhibited an exo-methylene group signal resonating at δ = 110.6 ppm. Signals 
at δ = 139.6 ppm, δ = 124.8 ppm and δ = 147.3 ppm were typical for C-5, C-6 and C-25. 
Carbon at δ = 83.5 ppm showed correlation to a proton at δ = 3.83 ppm (dd) and was 
identified as C-1. On the other hand some significant chemical shifts were noted for carbons 
from C-19 to C-27 in comparison to compound 1, indicating a different substructure. After 
analysis of the above mentioned carbon skeleton, using HMBC spectral data, an open ring 
structure has been confirmed. First clue was the non-present HMBC correlation between C-22 
and H-26, which was observed in HMBC of compound 1. Second fact leading to the final 
conclusion was a HMBC correlation between C-26 and an anomeric proton, later assigned as 
H-1'''. An open ring system of the furostanols is only stable with terminal sugar connected to 
C-26, therefore this signal was crucial for the confirmation of the structure (Fig. 3.11, p. 61).  
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Two more anomeric carbons at δ = 100.4 ppm and δ = 101.8 ppm correlating with protons at 
δ = 4.71 ppm (d) and δ = 6.34 ppm (s) suggested the presence of two more sugars. Comparing 
the signals with those from compound 1, it was expected that arabinose and rhamnose is 
connected to aglycone at C-1. Sugar signals were assigned using COSY and HMBC where H-
1' was identified as the anomeric proton of the arabinose and H-1'' as the anomeric proton of 
the rhamnose. A correlation between H-1' and C-1 in HMBC experiment unambiguously 
proved that arabinose is attached to the aglycone at C-1 (Fig. 3.9, p. 60). Correlation between 
H-2' and C-1'' confirmed the assumption that the rhamnose was attached to the arabinose at C-
2' (Fig. 3.10, p. 61). Sugar bound to the terminal C-26 carbon was identified as glucose. 3 was 
confirmed as deglucoruscoside by pseudomolecular ion peak at m/z: 885 [M-H]- in negative-
ion ESI-MS and data comparison to literature (Mimaki et al. 1998 b). 
Absolute stereochemistry via CE showed the presence of L-arabinose, L-rhamnose and D-
glucose which were identified as α-L-arabinose, α-L-rhamnose and β-D-glucose after 
analysing the 3JH-1'/H-2' values. 3JH-1'/H-2' = 7.4 Hz signified the presence of α-L-arabinose and a 
very small 3JH-1''/H-2'' value (could not be measured, therefore H-1' assigned as singlet) 
confirmed the presence of α-L-rhamnose. 3JH-1'''/H-2''' = 7.7 Hz value confirmed the presence of 
β-D-glucose. For α-D-glucose the J value would be much smaller. 
Compound 3 was submitted for further analysis concerning the stability and kinetics of C-22 
methoxy- and hydroxy- compounds (Origin of C-22 hydroxylated and methoxylated 
compounds p. 38).  
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Nr. C Nr. H 
1 83.5 1 3.83 dd (11.9, 3.8) 
2 37.4 2 2.73 m* 
2.35 q (11.9) 
3 68.2 3 3.86 m* 
4 43.9 4 2.69 m* 
2.56 dd (12.7, 3.8) 
5 139.6 5  
6 124.8 6 5.56 d (5.7) 
7 32.1 7 1.87 m* 
1.49 m* 
8 33.2 8 1.53 m* 
9 50.4 9 1.50 m* 
10 43.0 10  
11 24.1 11 2.98 m 
1.64 m* 
12 40.4 12 1.58 m* 
1.29 m* 
13 40.5 13  
14 56.8 14 1.12 m* 
15 32.7 15 1.99 m 
1.43 m* 
16 81.3 16 4.90 m* 
17 63.9 17 1.85 m* 
18 16.9 18 0.90 s 
19 15.1 19 1.44 s 
20 40.7 20 2.21 m* 
21 16.4 21 1.26 d (6.9) 
22 110.4 22  
23 38.0 23 2.21 m* 
24 28.4 24 2.68 m* 
 
25 147.3 25  
26 72.1 26 4.58 d (13.3) 
4.31 d (10.7) 
27 110.6 27 5.31 s 
5.02 s 
1’ 100.4 1’ 4.72 d (7.4) 
2’ 75.2 2’ 4.60 m* 
3’ 76.0 3’ 4.15 m* 
4’ 70.2 4’ 4.15 s broad 
5’ 67.4 5’ 4.25 d (11.9) 
3.65 d (12.0) 
1’’ 101.8 1’’ 6.34 s 
2’’ 72.6 2’’ 4.74 s broad 
3’’ 72.7 3’’ 4.64 dd (9.3, 3.1) 
4’’ 74.3 4’’ 4.32 m 
5’’ 69.5 5’’ 4.85 m* 
6’’ 19.1 6’’ 1.74 d (6.2) 
1’’’ 104.0 1’’’ 4.87 d (7.7) 
2’’’ 75.2 2’’’ 4.04 m* 
3’’’ 78.6 3’’’ 4.23 m* 
4’’’ 71.7 4’’’ 4.23 m* 
5’’’ 78.6 5’’’ 3.91 m* 
6’’’ 62.8 6’’’ 4.53 d (11.6) br. 
4.37 m* 
 
Table 3.2: 1H and 13C NMR data for compound 3 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in pyridine d-5, * - overlapping signals) 
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm 
 
Fig. 3.8: 1H spectrum (pyridine d-5, 600 MHz) of 3 with clearly separated areas of sugar and 
aglycone signals.  
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Fig. 3.9: HMBC correlation between C-1 (δ = 83.5 ppm) and H-1' (δ = 4.72 ppm) of 3, 
signifying the position of arabinose at position C-1 of the aglycone. 
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Fig. 3.10: HMBC correlation between C-2' (δ = 75.2 ppm) and H-1'' (δ = 6.34 ppm) of 3, 
signifying that rhamnose is attached to arabinose at position C-2'. 
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Fig. 3.11: HMBC correlation between C-26 (δ = 72.1 ppm) and H-1''' (δ = 4.87 ppm) of 3, 
signifying that glucose is attached to the aglycone at C-26. 
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3.1.3.4 Compound 4 (3'-O-acetyl-4'-O-sulfodeglucoruscin) 
 
 
 
 
 
Compound 4 (3.7 mg) was identified as a new saponin and has not been found in nature so far 
(Rf = 0.63 in standard system, p. 28, colored green after derivatization with anisaldehyde 
reagent). Several other sulfated and acetylated saponins have been reported and therefore used 
as a comparison for this compound (Mimaki et al. 1998 b). 
Like in other saponins, two major signal areas were observed in 1H NMR experiment, the 
aglycone area ranging between 1 - 3 ppm and the sugar area at around 3.5 - 5 ppm. As for 1, 
aglycone was identified to be neoruscogenin with typical methyl groups, C-1, C-5, C-6, C-25 
and exo-methylene C-27 carbon. Neoruscogenine skeleton was confirmed via COSY and 
HMBC experiments as for 1.  
Same as in 13C NMR spectrum of 1, two signals, at δ = 99.6 ppm and δ = 102.0 ppm, 
correlating with protons at δ = 4.85 ppm (d) and δ = 5.78 ppm (s) in HSQC, suggested the 
presence of two sugar moieties. In comparison to proton spectrum of compound 1 a notable 
shift for some signals of the sugar part have been observed. This was the first hint for 
structural deviation from 1. 
As in 1, sugars were identified as rhamnose attached to arabinose (C-2' correlation to H-1'' in 
HMBC, Fig. 3.14, p. 66), which is connected to C-1 of the aglycone (C-1 correlation to H-1' 
in HMBC, Fig. 3.13, p. 65). Capillary electrophoresis confirmed the presence of L-arabinose 
and L-rhamnose (Materials & Methods p. 30 and CE results p. 101). A relatively large 3JH-1'/H-
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2' value at 6.4 Hz signified the presence of α-L-arabinose and a very small 3JH-1''/H-2'' value 
(could not be measured, therefore H-1' was assigned as singlet) confirmed the presence of α-
L-rhamnose. 
Carbon signal at δ = 171.0 ppm correlated with methyl group at δ = 21.1 ppm indicated the 
presence of an acetyl group. Position of the acetyl at C-3' was confirmed via HMBC. 
Compound 4 gave a pseudomolecular ion peak at m/z: 827 [M-H]- in negative-ion ESI-MS. 
Mass (M = 828) was compared to the so far elucidated acetylated deglucoruscin, M = 748. A 
difference of 81 (calculated for a fragment bound to an hydroxyl group) indicated the 
presence of a sulfate group. HR-MS for compound 4 showed exact mass of [M+H]+ m/z 
829.3680 calculated for C40H61O16S1, which confirmed the assumption concerning the sulfate 
group. A high field shift of the C-4' suggested that the sulfate was bound to this carbon. Due 
to the fact that C-1' was connected to the aglycone, C-2' to the rhamnose, C-3' with the acetyl 
group and that C-5' was a methylene group, it was obvious that the sulfate group was bound to 
the C-4'. Signals for the rhamnose were comparable to those from the literature (Mimaki et al. 
1998 a/b/c, 1999, 2003, 2008).   
The optical rotation of 4 was measured [α] 24D  = -93.4 (c = 0.1, MeOH) and UV maximum at 
202 nm (0.1 mg/mL, ε = 7634 L/mol cm). 
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Nr. C Nr. H 
1 83.9 1 3.76 dd (11.9, 3.8) 
2 37.4 2 2.67 m* 
2.24 q* 
3 68.0 3 3.84 m* 
4 43.9 4 2.66 m* 
2.56 m 
5 139.4 5  
6 125.0 6 5.56 d (5.6) 
7 32.0 7 1.86 m* 
1.52 m* 
8 33.2 8 1.54 m* 
9 50.2 9 1.42 m* 
10 43.0 10  
11 24.1 11 2.83 m 
1.58 m* 
12 39.7 12 1.42 m* 
1.17 m* 
13 40.1 13  
14 56.6 14 1.07 m* 
15 32.4 15 1.98 m 
1.40 m* 
16 81.5 16 4.48 m 
17 62.8 17 1.65 m* 
18 16.6 18 0.82 s 
19 15.0 19 1.38 s 
20 41.9 20 1.88 m* 
21 14.9 21 0.99 d (7.0) 
22 109.4 22  
23 33.2 23 1.73 m* 
24 29.0 24 2.68 m* 
2.20 m* 
25 144.6 25  
26 65.0 26 4.43 d (12.1) 
3.99 d (12.1) 
27 108.6 27 4.78 s 
4.74 s 
1’ 99.6 1’ 4.85 d (6.4) 
2’ 73.5 2’ 4.62 m 
3’ 74.8 3’ 5.48 m* 
4’ 71.5 4’ 5.48 m* 
5’ 64.8 5’ 4.72 dd* 
3.80 d* 
1’’ 102.0 1’’ 5.78 s 
2’’ 72.3 2’’ 4.57 m 
3’’ 72.4 3’’ 4.53 dd (9.3, 3.3) 
4’’ 74.0 4’’ 4.29 t (9.4) 
5’’ 70.2 5’’ 4.69 m* 
6’’ 19.0 6’’ 1.75 d (6.1) 
-CO- 171.0   
-CH3 21.1  1.98 s 
-HSO3    
 
Table 3.3: 1H and 13C NMR data for compound 4 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in pyridine d-5, * - overlapping signals) 
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm 
 
Fig. 3.12: 1H spectrum (pyridine d-5, 600 MHz) of 4 with clearly separated areas of sugar and 
aglycone signals  
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Fig. 3.13: HMBC correlation between C-1 (δ = 83.9 ppm) and H-1' (δ = 4.85 ppm) of 4, 
confirming the position of arabinose at position C-1 of the aglycone. 
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Fig. 3.14: HMBC correlation between C-2' (δ = 73.5 ppm) and H-1'' (δ = 5.78 ppm) of 4, 
confirming that rhamnose is attached to arabinose at position C-2'. 
3JC-2'/H-1'' 
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3.1.3.5 Compound 5 (1-O-sulfo-ruscogenin) 
 
 
 
 
 
A 1-O sulfated saponin has been isolated and assigned as compound 5 (14.0 mg). 1H NMR 
experiment confirmed the presence of an aglycone and surprisingly no signals of sugar 
moieties between 3.5 - 5 ppm. Rf value of 5 on TLC (Rf = 0.55 in standard system, p. 28, 
colored green after derivatization with anisaldehyde reagent) was similar to those from other 
isolated saponins indicating that this compound was not an unsubstituted aglycone. This 
assumption was confirmed by ESI-MS where M = 510 was approved by the pseudomolecular 
ion at m/z: 509 [M-H]-) which is higher in comparison to the molecular weight of 
neoruscogenin (M = 428). 
NMR analysis of the aglycone showed the presence of ruscogenin. In 13C experiment no exo-
methylene group was found at around 109 ppm. Additionally, an extra methyl group 
resonating at δ = 0.67 ppm (d) in proton spectrum and correlated with C-25 in HMBC, was 
detected. COSY correlation between this methyl group and C-25 suggested ruscogenin 
skeleton. After comparing the signals with literature (Mimaki et al. 1998 a/b/c, 1999, 2003, 
2008) and thorough COSY and HMBC analysis of the aglycone, the presence of ruscogenin 
was confirmed (Table 3.4, p. 68 and Fig 3.15, p. 69). 
Molecular weight of ruscogenin is M = 430, leaving a total mass of 81 (510-(430-1)) for the 
attached substituent. Several sulfated compounds have already been isolated from R. 
aculeatus and therefore the presence of an O-sulfo ruscogenin was taken into consideration. A 
very pronounced downfield shift of C-1 (δ = 84.2 ppm), comparable to 1-O glycosides, 
signified that the sulfate was connected to the ruscogenin via C-1. 
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A potassium salt of 5 has already been found and published. (Oulad-Ali et al. 1996) 
Optical rotation of 5 was measured [α] 24D  = -53.2 (c = 0.1, MeOH) and UV maximum at 202 
nm (0.1 mg/mL, ε = 4702 L/mol cm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.4: 1H and 13C NMR data for compound 5 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in pyridine d-5, * - overlapping signals) 
Nr. C Nr. H 
1 84.2 1 4.75 dd (11.9,4.2) 
2 39.8 2 3.52 m*  
2.29 q (11.9) 
3 68.0 3 3.88 m 
4 43.7 4 2.65 m  
2.54 m 
5 139.0 5  
6 125.2 6 5.55 d (5.8) 
7 31.9 7 1.83 m*  
1.45 m* 
8 33.1 8 1.54 m* 
9 49.9 9 1.70 m* 
10 43.2 10  
11 23.7 11 3.06 m  
1.61 m* 
12 40.7 12 1.67 m*  
1.32 m* 
13 40.2 13  
14 56.7 14 1.07 m* 
15 32.4 15 1.99 m*  
1.42 m* 
16 81.1 16 4.5 m 
17 63.1 17 1.70 m* 
18 16.7 18 0.83 s 
19 14.8 19 1.29 s 
20 41.9 20 1.89 m* 
21 15.1 21 1.08 d (7.0) 
22 109.3 22  
23 31.9 23 1.66 m*  
1.61 m* 
24 29.3 24 1.54 m* 
25 30.6 25 1.55 m* 
26 66.8 26 3.55 m*  
3.48 m* 
27 17.3 27 0.67 d (5.6) 
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm 
 
Fig. 3.15: 1H spectrum (pyridine d-5, 600 MHz) of 5 with signals of the aglycone part and 
missing sugar signals in comparison to compound 1.  
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3.1.3.6 Compound 6 (4'-O-(2-hydroxy-3-methylpentanoyl)-deglucoruscin) 
 
 
 
Compound 6 (13.4 mg) was found to be a new steroidal saponin (Rf = 0.68 in standard 
system, p. 28, colored green with anisaldehyde reagent). Signals in 13C experiment indicated 
the presence of a neoruscogenin aglycone with two sugars attached (Table 3.5, p. 71 and Fig. 
3.16, p. 72). Further NMR analysis (see 1, p. 51) showed the presence of rhamnose attached 
to arabinose (C-2' correlation to H-1'' in HMBC, Fig. 3.18, p. 73), which is connected to C-1 
of the aglycone (C-1 correlation to H-1' in HMBC, Fig. 3.17, p. 72). CE showed the presence 
of L-arabinose and L-rhamnose (p. 30 and 101). A relatively large 3JH-1'/H-2' was observed, but 
could not be determined due to overlapping, signified the presence of α-L-arabinose. A very 
small 3JH-1''/H-2'' value (could not be measured, therefore H-1' assigned as singlet) confirmed 
the presence of α-L-rhamnose. Additional aliphatic side chain was considered due to presence 
of additional carbons not belonging to a sugar skeleton. Hydroxylated carbons exhibited 
normally chemical shift values between δ = 70 - 75 ppm in 13C spectrum with anomeric 
carbons resonating at around δ = 100 ppm. A low field signal at δ = 175.1 ppm suggested the 
presence of an acetyl group. COSY and HMBC were used to determine the side chain as a 2-
hydroxy-3-methylpentanoat connected to the arabinose via C-4' (Fig. 3.19, p. 73). Negative-
ion ESI-MS gave m/z: 819 [M-H]-. Optical rotation of 6 was measured [α] 24D  = -34.7 (c = 0.1, 
MeOH) and UV maximum at 202 nm (0.1 mg/mL, ε = 6396 L/mol cm). 
RESULTS & DISCUSSION 
 71 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.5: 1H and 13C NMR data for compound 6 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in pyridine d-5, * - overlapping signals)  
Nr. C Nr. H 
1 83.0 1 3.82 dd (12.0, 3.8) 
2 37.3 2 2.67 m* 
2.35 q (12.0) 
3 68.2 3 3.86 m 
4 43.8 4 2.69 m* 
2.58 dd (12.7, 3.5) 
5 139.5 5  
6 124.7 6 5.58 d (5.7) 
7 31.9 7 1.89 m* 
1.52 m* 
8 33.1 8 1.59 m 
9 50.3 9 1.53 m* 
10 42.8 10  
11 24.3 11 2.99 m 
1.74 m* 
12 40.6 12 1.90 m* 
1.43 m* 
13 40.4 13  
14 57.0 14 1.13 m* 
15 32.4 15 2.01 m 
1.46 m* 
16 81.5 16 4.51 m 
17 63.1 17 1.81 m* 
18 16.9 18 0.95 s 
19 15.0 19 1.43 s 
20 41.9 20 2.01 m 
21 15.0 21 1.16 d (7.0) 
22 109.5 22  
23 33.3 23 1.79 m 
24 29.0 24 2.71 m* 
2.23 m 
25 144.5 25  
26 65.0 26 4.45 d (12.2) 
4.00 d (12.1) 
27 108.7 27 4.79 s 
4,76 s 
1’ 99.9 1’ 4.70 d* 
2’ 75.3 2’ 4.41 dd (9.1, 7.8) 
3’ 73.7 3’ 4.28 m* 
4’ 73.1 4’ 5.53 s 
5’ 64.6 5’ 4.13 dd (13.0, 1.9) 
3.67 d (12.8) 
1’’ 102.1 1’’ 6.22 s 
2’’ 72.5 2’’ 4.69 m 
3’’ 72.7 3’’ 4.59 dd* 
4’’ 74.3 4’’ 4.31 t (9.5) 
5’’ 69.6 5’’ 4.82 m 
6’’ 19.2 6’’ 1.76 d (6.2) 
1’’’ 175.1 1’’’  
2’’’ 75.8 2’’’ 4.6 m* 
3’’’ 39.7 3’’’ 2.28 m 
4’’’ 24.7 4’’’ 2.07 m 
1.62 m* 
5’’’ 16.1 5’’’ 1.27 d (6.8) 
 
6’’’ 12.2 6’’’ 1.07 d (7.4) 
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm 
 
Fig. 3.16: 1H spectrum (pyridine d-5, 600 MHz) of 6 with clearly separated areas of sugar and 
aglycone signals.  
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Fig. 3.17: HMBC correlation between C-1 (δ = 83.0 ppm) and H-1' (δ = 4.70 ppm) of 6, 
signifying the position of arabinose at position C-1 of the aglycone. 
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Fig. 3.18: HMBC correlation between C-2' (δ = 75.3 ppm) and H-1'' (δ = 6.22 ppm) of 6, 
signifying that rhamnose is attached to arabinose at position C-2'. 
 
 
 
 
ppm
5.255.305.355.405.455.505.555.605.655.705.75 ppm
170
171
172
173
174
175
176
177
178
179
 
 
Fig. 3.19: HMBC correlation between C-1''' (δ = 175.1 ppm) and H-4' (δ = 5.53 ppm) of 6, 
signifying that 2-hydroxy-3-methylpentanoat is connected to the arabinose via C-4'. 
3JC-2'/H-1'' 
3JC-1'''/H-4' 
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3.1.3.7 Compound 7 (4'-O-acetyl-deglucoruscin) 
 
 
 
Compound 7 (1.8 mg) has been reported for the first time (Rf = 0.68 in standard system, p. 
28, colored green after derivatization with anisaldehyde reagent). Carbon spectrum was 
compared to the spectrum of 1 (see 1, p. 51) and suggested the presence of neoruscogenin as 
aglycone. The structure of neoruscogenine exhibiting a typical signal pattern in 13C and 1H 
NMR spectrum (see 1, p. 51) was confirmed via COSY and HMBC experiments. Thorough 
NMR analysis showed the presence of rhamnose attached to arabinose (C-2' correlation to H-
1'' in HMBC, Fig. 3.22, p. 77), which is connected to C-1 of the aglycone (C-1 correlation to 
H-1' in HMBC, Fig. 3.21, p. 76). Capillary electrophoresis confirmed this assumption by 
showing the presence of L-arabinose and L-rhamnose (Materials & Methods p. 30 and CE 
results p. 101). A relatively large 3JH-1'/H-2' at 7.4 Hz signified the presence of α-L-arabinose 
and a very small 3JH-1''/H-2'' value (too small to be visible in the 1H NMR spectrum, therefore 
H-1' was assigned as singlet) indicated the presence of α-L-rhamnose. 
Carbon at 170.9 ppm showing correlations with the protons of the methyl group resonating at 
1.98/21.0 ppm in HMBC experiment showed the presence of an acetyl group (Fig. 3.23, p. 
77). Due to low amount of 7, no clear correlation between carboxyl group (δ = 170.9 ppm) 
and H-4' was found. Position of acetyl group at C-4' was assigned due to high shift of H-4' in 
proton spectrum. With the negative-ion ESI-MS with m/z: 747 [M-H]- a 4'-O acetylated 
deglucoruscin structure was confirmed.  Optical rotation of 7 [α] 24D  = -39.5 (c = 0.1, MeOH) 
and UV maximum at 202 nm (0.1 mg/mL, ε = 6725 L/mol cm) were measured. 
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Nr. C Nr. H 
1 83.2 1 3.79 dd (12.1, 3.8) 
2 37.5 2 2.66 m* 
2.38 q (12.0) 
3 68.2 3 3.86 m 
4 43.7 4 2.68 m* 
2.58 dd (12.5, 3.8) 
5 139.4 5  
6 124.3 6 5.58 d (5.3) 
7 31.9 7 1.89 m* 
1.54 m* 
8 33.1 8 1.58 m* 
9 50.3 9 1.54 m 
10 42.6 10  
11 24.4 11 2.96 m 
1.68 m* 
12 40.5 12 1.74 m* 
1.34 m* 
13 40.3 13  
14 57.1 14 1.13 m 
15 32.3 15 2.01 m* 
1.46 m* 
16 81.4 16 4.51 m* 
17 63.1 17 1.75 m* 
18 16.9 18 0.92 s 
19 15.0 19 1.43 s 
20 41.8 20 1.96 m* 
21 14.9 21 1.07 d (6.9) 
22 109.5 22  
23 33.2 23 1.76 m* 
24 29.0 24 2.70 m* 
2.23 m 
25 144.4 25  
26 65.0 26 4.45 d* (12.4) 4.01 d 
(12.1) 
27 108.6 27 4.78 d (19.2) 
1’ 100.0 1’ 4.67 d (7.4) 
2’ 75.3 2’ 4.47 m* 
3’ 73.7 3’ 4.25 m* 
4’ 73.2 4’ 5.38 s 
5’ 64.3 5’ 4.22 dd (13.1, 1.8) 
3.63 d (12.9) 
1’’ 102.0 1’’ 6.31 s 
2’’ 72.5 2’’ 4.71 s (Br) 
3’’ 72.7 3’’ 4.60 dd (9.3, 3.0) 
4’’ 74.2 4’’ 4.32 t (9.4) 
5’’ 69.6 5’’ 4.86 m* 
6’’ 19.2 6’’ 1.78 d (6.1) 
-CO- 170.9   
-CH3 21.0  1.98 s 
 
 
Table 3.6: 1H and 13C NMR data for compound 7 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in pyridine d-5, * - overlapping signals) 
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm 
 
Fig. 3.20: 1H spectrum (pyridine d-5 600 MHz) of 7 with clearly separated areas of sugar and 
aglycone signals.  
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Fig. 3.21: HMBC correlation between C-1 (δ = 83.2 ppm) and H-1' (δ = 4.67 ppm) of 7, 
confirming the position of arabinose at position C-1 of the aglycone. 
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Fig. 3.22: HMBC correlation between C-2' (δ = 75.3 ppm) and H-1'' (δ = 6.31 ppm) of 7, 
confirming that rhamnose is attached to arabinose at position C-2'. 
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Fig. 3.23: HMBC correlation between carboxyl group (δ = 170.9 ppm) and methyl group (δ = 
1.98 ppm) of 7. 
3JC-2'/H-1'' 
3JC=O/H-4' 
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3.1.3.8 Compound 8 (Ruscin) 
 
 
 
 
Compound 8 (87.4 mg) was identified as one of the most abundant steroid saponins from R. 
aculeatus, namely ruscin (Rf = 0.39 in standard system, p. 28, colored green after 
derivatization with anisaldehyde reagent). As in 1, aglycone was identified as the 
neoruscogenine. Typical signals, such as methyl groups of the aglycone, H3-18 at δ = 0.83 
ppm (s), H3-19 at δ = 1.45 ppm (s) and H3-21 at δ = 1.07 ppm (d) were found in 1H spectrum. 
In the 13C spectrum a signal an exo-methylene group was found at δ = 110.6 ppm belonging 
to C-27. Signals at δ = 139.5 ppm, δ = 124.8 ppm and δ = 144.5 ppm are typical for C-5, C-6 
and C-25. A carbon resonating at δ = 84.8 ppm that showed correlation to a proton at δ = 3.73 
ppm (dd) in HSQC was identified as C-1 and is also a very characteristic signal for 
neoruscogenin (Mimaki et al. 1998 b). 
Three signals, at δ = 101.2 ppm, at δ = 101.3 ppm and at δ = 106.6 ppm, correlating with 
protons at δ = 4.60 ppm (d), δ = 6.36 ppm (s) and δ = 5.65 ppm (d), most likely belong to 
anomeric protons and carbons and suggested the presence of three sugars. As 27 carbons 
belong to the neoruscogenin skeleton, the remaining 17 signals also indicated the presence of 
three sugars, two hexoses and one pentose. Further NMR analysis (see 1, p. 51) showed the 
presence of glucose attached to rhamnose (C-3'' correlation to H-1''' in HMBC, Fig. 3.27, p. 
82) attached to arabinose (C-2' correlation to H-1'' in HMBC, Fig. 3.26, p. 82), which is 
connected to C-1 of the aglycone (C-1 correlation to H-1' in HMBC, Fig. 3.25, p. 81). 
Capillary electrophoresis confirmed the presence of L-arabinose, L-rhamnose and D-glucose 
(Materials & Methods p. 30 and CE results p. 101). A relatively large 3JH-1'/H-2' was observed 
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(not measured due to overlapping), which indicated the presence of α-L-arabinose and a very 
small 3JH-1''/H-2'' value (not visible in the 1H NMR spectrum, therefore H-1' was assigned as 
singlet) signified α-L-rhamnose. 3JH-1'''/H-2''' = 7.9 confirmed the presence of β-D-glucose. 
A pseudomolecular ion peak at m/z: 867 [M-H]- in negative-ion ESI-MS confirmed 
compound 8 as ruscin (Hänsel & Sticher 2007). 
Optical rotation of 8 [α] 24D  = -91.0 (c = 0.1, MeOH) and UV maximum at 201 nm (0.1 
mg/mL, ε = 10364 L/mol cm) were measured. 
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Nr. C Nr. H 
1 84.8 1 3.73 dd (11.9, 4.0) 
2 38.1 2 2.75 m* 
2.45 q (11.9) 
3 68.2 3 3.85 m 
4 43.8 4 2.69 m* 
2.55 dd (12.8, 3.1) 
5 139.5 5  
6 124.8 6 5.55 d (5.7) 
7 32.0 7 1.85 m* 
1.51 m* 
8 33.0 8 1.54 m* 
9 50.5 9 1.47 m* 
10 42.9 10  
11 23.9 11 2.96 m 
1.59 m* 
12 40.3 12 1.49 m* 
1.25 dt (6.4, 3.5) 
13 40.2 13  
14 56.8 14 1.09 m 
15 32.3 15 1.98 m 
1.42 m* 
16 81.4 16 4.49 m* 
17 63.0 17 1.71 m* 
18 15.0 18 0.83 s 
19 16.7 19 1.45 s 
20 41.8 20 1.89 m* 
21 15.1 21 1.02 d (7.0) 
22 109.4 22  
23 33.2 23 1.74 m* 
24 28.9 24 2.68 m* 
2.21 m 
25 144.5 25  
26 64.9 26 4.43 d (12.2) 
4.00 d (12.1) 
27 108.6 27 4.76 d (19.9) 
1’ 101.2 1’ 4.60 d* 
2’ 74.2 2’ 4.57 m* 
3’ 76.2 3’ 4.09 m* 
4’ 78.3 4’ 4.12 m* 
5’ 67.7 5’ 4.24 d* 
3.63 d (11.8) 
1’’ 101.3 1’’ 6.36 s 
2’’ 72.1 2’’ 4.95 m 
3’’ 82.7 3’’ 4.87 dd (9.5, 2.9) 
4’’ 73.3 4’’ 4.52 m* 
5’’ 69.3 5’’ 4.90 m* 
6’’ 18.7 6’’ 1.66 d (6.2) 
1’’’ 106.6 1’’’ 5.65 d (7.9) 
2’’’ 76.1 2’’’ 4.09 m* 
3’’’ 78.3 3’’’ 4.23 m* 
4’’’ 71.7 4’’’ 4.23 m* 
5’’’ 70.2 5’’’ 4.12 m* 
6’’’ 62.5 6’’’ 4.48 m* 
4.43 m* 
 
Table 3.7: 1H and 13C NMR data for compound 8 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in pyridine d-5, * - overlapping signals) 
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm 
 
Fig. 3.24: 1H spectrum (pyridine d-5, 600 MHz) of 8 with clearly separated areas of sugar and 
aglycone signals.  
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Fig. 3.25: HMBC correlation between C-1 (δ = 84.8 ppm) and H-1' (δ = 4.60 ppm) of 8, 
confirming the position of arabinose at C-1 of the aglycone. 
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Fig. 3.26: HMBC correlation between C-2' (δ = 74.2 ppm) and H-1'' (δ = 6.36 ppm) of 8, 
confirming that rhamnose is attached to arabinose at position C-2'. 
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Fig. 3.27: HMBC correlation between C-3'' (δ = 82.7 ppm) and H-1''' (δ = 5.65 ppm) of 8, 
confirming that glucose is attached to the rhamnose at C-3''. 
3JC-2'/H-1'' 
3JC-3''/H-1''' 
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3.1.3.9 Compound 9 (Ruscogenin-1-O-(O-α-L-rhamnopyranosyl-(1 → 2)-β-D-
galactopyranoside)) 
 
 
 
 
 
Compound 9 (11.1 mg) was identified as a known ruscogenin-type saponin (Rf = 0.43 in 
standard system, p. 28, colored green after derivatization with anisaldehyde reagent) and 
described by Mimaki et al. 1998 a. In 13C experiment no exo-methylene group resonated 
around 109 ppm and an extra methyl group at δ = 0.67 ppm (d) in proton spectrum, 
correlating with C-25 in HMBC, indicated a C-27 methyl group. COSY correlation between 
this methyl group and C-25 also suggested the presence of a ruscogenin skeleton. After 
comparing the signals with literature (Mimaki et al. 1998 a/b/c, 1999, 2003, 2008) and further 
COSY and HMBC analysis of the aglycone, presence of ruscogenine was confirmed (Table 
3.8, p. 85 and Fig. 3.28, p. 86). 
Two signals at δ = 100.7 ppm and δ = 101.7 ppm correlating with protons at δ = 4.77 ppm (d) 
assigned as H-1' and δ = 6.38 ppm (d) assigned as H-1'' and typical for anomeric protons and 
carbons suggested the presence of two sugars. Sugar signals were assigned using COSY and 
HMBC where H-1' was identified as the anomeric proton of the galactose and H-1'' as the 
anomeric proton of the rhamnose. HMBC correlation between H-1' and C-1 confirmed that 
galactose is attached to the aglycone at C-1 (Fig. 3.29, p. 86). Correlation between H-2' and 
C-1'' pointed out that the rhamnose is attached to the galactose at C-2' (Fig. 3.30, p. 87). 
Capillary electrophoresis confirmed the presence of D-galactose and L-rhamnose (Materials 
& Methods p. 30 and CE results p. 101). A relatively large 3JH-1'/H-2' value at 7.7 Hz signified 
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the presence of β-D-galactose and a very small 3JH-1''/H-2'' value at 0.9 Hz proved the presence 
of α-L-rhamnose.  
A pseudomolecular ion peak at m/z 737 [M-H]- in negative-ion ESI-MS and comparison 
literature data confirmed the presence of already published compound. 
Optical rotation of 9 [α] 24D  = -102.0 (c = 0.1, MeOH) and UV maximum at 202 nm (0.1 
mg/mL, ε = 5756 L/mol cm) was measured. 
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Nr. C Nr. H 
1 84.3 1 3.83 dd (12.0, 4.1) 
2 38.0 2 2.69 m* 
2.41 q (12.0) 
3 68.2 3 3.80 m* 
4 43.9 4 2.68 m* 
2.55 ddd (12.7, 0.1, 0.9) 
5 139.6 5  
6 124.8 6 5.56 d (5.8) 
7 32.0 7 1.86 m* 
1.53 m* 
8 33.1 8 1.57 m* 
9 50.6 9 1.57 m* 
10 42.9 10  
11 24.1 11 3.02 m* 
1.58 m* 
12 40.5 12 1.60 m* 
1.37 m* 
13 40.2 13  
14 57.1 14 1.15 m 
15 32.4 15 2.00 m 
1.43 m* 
16 81.2 16 4.46 m* 
17 63.0 17 1.76 dd* 
18 16.9 18 0.86 s 
19 15.1 19 1.43 s 
20 42.0 20 1.90 m* 
21 15.0 21 1.03 d (7.0) 
22 109.3 22  
23 31.8 23 1.66 m* 
1.61 m* 
24 29.3 24 1.54 m* 
25 30.7 25 1.55 m* 
26 66.9 26 3.56 m 
3.47 m 
27 17.4 27 0.67 d (5.6) 
1’ 100.7 1’ 4.77 d (7.7) 
2’ 75.0 2’ 4.63 dd (9.2, 7.8) 
3’ 76.8 3’ 4.18 m 
4’ 70.5 4’ 4.49 m* 
5’ 76.4 5’ 3.93 t (6.4) 
1’’ 62.0 1’’ 4.49 m* 
4.34 m* 
1’’ 101.7 1’’ 6.38 d (0.9) 
2’’ 72.6 2’’ 4.75 m* 
3’’ 72.7 3’’ 4.65 dd* 
4’’ 74.3 4’’ 4.31 t (9.5) 
5’’ 69.3 5’’ 4.91 m 
6’’ 19.1 6’’ 1.75 d (6.2) 
 
Table 3.8: 1H and 13C NMR data for compound 9 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in pyridine d-5, * - overlapping signals) 
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm 
 
Fig. 3.28: 1H spectrum (pyridine d-5, 600 MHz) of 9 with clearly separated areas of sugar and 
aglycone signals.  
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Fig. 3.29: HMBC correlation between C-1 (δ = 84.3 ppm) and H-1' (δ = 4.77 ppm) of 9, 
confirming the position of galactose at C-1 of the aglycone. 
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Fig. 3.30: HMBC correlation between C-2' (δ = 75.0 ppm) and H-1'' (δ = 6.38 ppm) of 9, 
confirming that rhamnose is attached to galactose at position C-2'. 
3JC-2'/H-1'' 
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3.1.4 Identification of phenolic compounds 
3.1.4.1 Compound 10 (Esculin) 
 
 
 
 
 
 
Compound 10 (< 1 mg) was identified as the well known and widespread coumarin esculin. 
Nevertheless, this is the first report of esculin isolated from R. aculeatus. 
On a TLC plate, 10 was observed as a very intensive blue fluorescence spot, suggesting the 
presence of a caffeic acid derivative (Rf = 0.54 in standard system, p. 28, colored fluorescent 
blue under UV at 366 nm). NMR proton spectrum showed the presence of a sugar and only 4 
aromatic protons belonging to the aglycone (Fig. 3.31, p. 89). A signal at δ = 164.2 in 13C 
experiment indicated the presence of a carbonyl group. Four other quaternary carbons were 
also found with the help of HMBC spectra. Furthermore, position of two benzene ring protons 
(singlets) were assigned in 1,4 position. HMBC experiment also showed that the sugar (Fig. 
3.32, p. 90), is attached to the coumarin at C-6. Two other aromatic carbons resonated at 
145.3 ppm and 153.0 ppm suggesting the presence of hydroxyl or alkoxy groups. With all this 
fragments identified and further HMBC and COSY correlations, structure of esculin was 
proposed and confirmed by ESI-MS giving a m/z 339 [M-H]- for the pseudomolecular ion. 
Sugar was identified as glucose. Due to a very low weight (< 1 mg), no further experiments 
were conducted on compound 10. 
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Nr. C Nr. H 
2 164.2 2  
3 111.8 3 6.15 d (9.4) 
4 146.3 4 7.81 d (9.4) 
5 116.2 5 7.35 s 
6 145.3 6  
7 156.0 7  
8 104.8 8 6.75 s 
9 111.8 9  
10 153.0 10  
1’ 104.3 1’ 4.81 d (7.6) 
2’ 74.8 2’ 3.51 m* 
3’ 77.6 3’ 3.47 m* 
4’ 71.4 4’ 3,38 m 
5’ 78.5 5’ 3.46 m* 
6’ 62.6 6’ 3.93 dd (12.0, 2.1) 
3.71 dd (12.0, 6.0) 
 
Table 3.9: 1H and 13C NMR data for compound 10 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in MeOD d-4, * - overlapping signals) 
 
 
 
 
4.04.55.05.56.06.57.07.5 ppm 
 
Fig. 3.31: 1H spectrum (methanol d-4, 600 MHz) of 10 with signals of glucose and aglycone.  
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Fig. 3.32: HMBC correlation between C-6 (δ = 145.3 ppm) and H-1' (δ = 4.81 ppm) of 10, 
confirming the position of glucose at C-6 of the aglycone. 
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3.1.4.2 Compound 11 (Ruscozepine A) 
 
 
 
 
   
 
Compound 11 (0.3 mg) was found to be a compound with a novel skeleton and its synthesis 
via one of the classical biosynthetic pathway for aromatic compounds is hard to explain. TLC 
chromatograms sprayed with anisaldehyde reagent gave purple coloration for 11 at VIS (Rf = 
0.41 developed in DCM:MeOH:H2O = 90:10:1 on RP-18 plate). 
Several signals in 1H NMR experiment indicated the presence of a phenolic compound with 
two phenolic ring ssystems (Fig. 3.33, p. 92). Three low field shifted signals in 13C NMR 
spectrum suggested three hydroxy groups attached to the aromatic rings. Two carbon signals 
at 130.4 ppm and 116.2 ppm coupled in HSQC with protons at 7.04 and 6.71 ppm, which 
were integrated by 2 and correlating in COSY (Fig. 3.34, p. 93), pointed to the presence of a 
p-substituted benzene ring. A HMBC experiment confirmed via a correlation of H-3 (3.83 
ppm) and C-1′ (133.5 ppm) that C-1' was attached to C-3 resonating at 50.7 ppm and that C-4' 
was hydroxylated (δ = 157.4 ppm). A correlation between H-3/H-2 (showing for H-2 the 
typical shift value and signal pattern of a oxygen substituted methylene group in a ring 
system, δ = 4.20 ppm, ddd, J = 11.6, 3.2, 0.8 and 4.04 dd, J = 11.7, 6.7) and between H-3/H-4 
(showing the typical shift value of a methin proton belonging to a double bond, δ = 5.76 ppm, 
dd J = 11.8, 4.0) was found in the COSY experiment and allowed one important step to the 
building of the seven-membered ring system. Presence of the methylene character of C-2 was 
shown in the HSQC experiment. Its low field shift at 76.4 ppm in 13C confirmed that it is 
bound to oxygen. Furthermore, H-4 is correlated to H-5 in COSY and a HMBC correlation 
between H-5 and aromatic C-11 indicated thar the seven-membered ring is annelated to one of 
the phenolic rings. This was also confirmed by a HMBC correlation between H-2 and C-10. 
Since the aromatic C-10 resonated down field shifted (δ = 161.7 ppm) it was clear that both 
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C-10 and C-2 were bound to the same oxygen. With HMBC and COSY, it was possible to 
assign the rest of the signals where C-8 (δ = 158.8 ppm) was carrying the second hydroxyl 
group. 
Structure was confirmed by a HR-MS giving a molecular ion with exact mass of m/z 
254.0943 [M+] calculated for C16H14O3. 
Due to low amount, compound 11 was not submitted for any further testing. UV maxima at 
222, 267 and 300 nm (in MeOH) were measured. 
 
Nr. C Nr. H 
2 76.4 2 4.20 ddd (11.6, 3.2, 0.8) 
4.04 dd (11.7, 6.7) 
3 50.7 3 3.83 m 
4 131.1 4 5.76 dd (11.8, 4.0) 
5 128.9 5 6.35 dd* 
6 134.8 6 7.05 m* 
7 111.0 7 6.45 dd (8.4, 2.5) 
8 158.8 8  
9 107.3 9 6.34 d* (2.5) 
10 161.7 10  
11 120.0 11  
1’ 133.5 1’  
2’ 130.4 2’ 7.04 m* 
3’ 116.2 3’ 6.71 m* 
4’ 157.4 4’  
5’ 116.2 5’ 6.71 m* 
6’ 130.4 6’ 7.04 m* 
 
Table 3.10: 1H and 13C NMR data for compound 11 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in MeOD d-4, * - overlapping signals) 
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3.54.04.55.05.56.06.57.0 ppm 
 
Fig. 3.33: 1H spectrum (methanol d-4, 600 MHz) of 11. 
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Fig. 3.34: COSY spectrum of compound 11 with highlighted key correlations. 
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3.1.4.3 Compound 12 (1-(2- hydroxyethyl)-3,4-dihydroxy benzene) 
 
 
 
 
 
 
Compound 12 was identified as already known compound. Its consistency was found to be 
very oily and therefore difficult to weight exactly (around 7 mg, Rf = 0.25 developed in 
DCM:MeOH:H2O = 90:10:1). 
1H NMR spectrum indicated the presence of a simple phenolic compound (Fig. 3.35, p.95). 
The presence of six aromatic and two aliphatic carbons was confirmed in 13C experiment. 
Two of the aromatic carbons (δ = 146.1 ppm and (δ = 144.6 ppm) downfield shifted, 
suggesting two hydroxyl groups. Alifatic signals were assigned as hydroxyethyl due to the 
presence of two methylene groups and a downfield shift of C-2' (δ = 64.6 ppm). Positions of 
all substituents were confirmed via HMBC and COSY. 
Structure was confirmed by ESI-MS giving a m/z: 153 [M-H]- for the pseudomolecular ion. 
Due to characteristics of 12 (oily and hydrophilic and therefore impossible to get an exact 
weight), no further experiments were performed.  
UV maxima at 224 and 279 nm (in MeOH) were measured. 
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Nr. C Nr. H 
1 131.8 1  
2 117.1 2 6.64 d (1.9) 
3 146.1 3  
4 144.6 4  
5 116.3 5 6.66 d (8.0) 
6 121.2 6 6.51 dd (8.1, 2.0) 
1’ 39.7 1’ 2.65 t (7.2) 
2’ 64.6 2’ 3.66 t (7.3) 
 
Table 3.11: 1H and 13C NMR data for compound 12 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in MeOD d-4, * - overlapping signals) 
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Fig. 3.35: 1H spectrum (methanol d-4, 600 MHz, 298 K) of 12 with expansions. 
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Fig. 3.36: COSY spectrum of compound 12 with highlighted key correlations. 
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3.1.4.4 Compound 14 (Ruscozepine B) 
 
 
 
 
 
 
Compound 14 (1.2 mg) was also found to be a new compound with a novel skeleton and 
being structurally related to 11. TLC chromatograms sprayed with anisaldehyde gave purple 
coloration for 14 at VIS (Rf = 0.36 developed in MeOH:H2O = 7:3 on RP-18 plate). 
Signal pattern of 14 was very similar to the one from compound 11. The main difference was 
observed in additional methyl group (δ = 56.4 ppm in carbon and δ = 3.80 ppm (s) in proton 
spectrum, Table 3.12, p. 98 and Fig. 3.37, p. 99) and a possible extra hydroxyl group due to a 
downfield shift of C-7 (111.0 ppm for 11 and 142.5 ppm for 14). A downfield shifted methyl 
group indicated the presence of a methoxy group, which was confirmed by a missing aromatic 
proton (H-7 in compound 11). The other benzene ring had exactly the same chemical shifts as 
the ring in 11. Position of the methoxy group was confirmed by HMBC. As in compound 11, 
structure was assigned using COSY and HMBC and confirmed by HR-MS with the exact 
mass signal 284.1049 [M+] calculated for C17H16O4. 
Optical rotation of 14 [α] 24D  = -98.9 (c = 0.1, MeOH) and UV maxima at 230 nm, 273 nm and 
307 nm (0.1 mg/mL, ε = 3300 at 307 nm) were measured. 
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Nr. C Nr. H 
2 76.7 2 4.18 dd (11.3, 3.6) 
4.03 dd (11.6, 6.7) 
3 50.9 3 3.83 m 
4 128.6 4 5.81 dd (11.9, 4.1) 
5 132.5 5 6.28 dd (11.9, 1.9) 
6 119.1 6 6.66 s 
7 142.5 7  
8 148.7 8  
9 104.7 9 6.52 s 
10 154.3 10  
11 120.3 11  
1’ 133.5 1’  
2’ 130.4 2’ 7.04 m* 
3’ 116.2 3’ 6.71 m* 
4’ 157.4 4’  
5’ 116.2 5’ 6.71 m* 
6’ 130.4 6’ 7.04 m* 
-OMe 56.4 -OMe 3.80 s 
 
Table 3.12: 1H and 13C NMR data for compound 14 (δ in ppm, J in Hz, 600 MHz for 1H and 
150 MHz for 13C, 298 K, in MeOD d-4, * - overlapping signals) 
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3.54.04.55.05.56.06.57.0 ppm 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.37: 1H spectrum (methanol d-4, 600 MHz, 298 K) of 14 with expansion. 
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Fig. 3.38: COSY spectrum of compound 14 with highlighted key correlations. 
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3.1.5 Absolute stereochemistry of sugars determined by CE 
Absolute stereochemistry of the sugars present in compounds isolated from R. aculeatus was 
determined via capillary electrophoresis according to Noe & Freissmuth 1995. This method 
separates compounds based on their size and charge in a fused silica capillary. Capillaries of 
different size are connected with two buffer containers and electrodes, where detector, 
normally based on UV, is placed on the cathode side. All compounds travel into same 
direction due to the electroosmotic flow (EOF) and are separated due to their electrophoretic 
mobility. Positive ions travel to the cathode faster than negatively charged. Uncharged 
particles normally migrate together with EOF.   
Voltages up to 35 kV can be applied. For the use of voltages higher that 20 kV a change of 
cooling system is recommended. Water cooling can cause sparkling through the capillary 
wall, which eventually leads to very high electrical currents and breakdown of electroosmosis.  
Detector, normally UV detector, sends signals to the computer, where the separation can be 
observed in a form of a plot called electropherogram.  
 
In order to determine the absolute stereochemistry of the sugars in glycosides, they need to be 
hydrolysed from aglycone. This needs exposition to acidic conditions at high temperatures. In 
order to separate L and D enantiomers, a transformation into diastereoisomers must be 
performed. In this work, S-(-)-1-phenylethylamin has been used to derivatize the sugars. 
Samples as well as commercially available and with phenyletylamin derivatized reference 
sugars were applied to CE. Signals in electropherogram were assigned by addition of the 
authentic sugars (spiking) to the mixture of all sugars.  
A mixture of reference sugars was injected to get a clean plot of the authentic compounds 
(Fig. 3.39, p. 102). Sugar type was determined by injection and analysis of the sugar mixture 
obtained from the hydrolysis of the isolated compounds (Fig. 3.40, p. 103 and Fig. 3.42, p. 
104). With this experiment, we have also proven that separation of investigated sugars 
occurred. In order to confirm the type of the sugar and to assign absolute stereochemistry of 
the sugars from isolated compounds, the mixture of reference sugars was spiked with sugars 
from isolated compounds (Fig. 3.41, p. 103 and Fig. 3.43, p. 104). For derivatization, only 
compound 8 and 9 were used, due to the low yield of the other glycosides. They contain all 
types of monosaccharides that were found in compounds isolated during this thesis. It is most 
likely that the same monosaccharide enantiomer is part of the other glycosides present in 
Rusci rhizoma. As reference, all D and L enantiomers were used, except for rhamnose. The 
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only commercially available rhamnose enantiomer was the L-rhamnose. Thereby, it could not 
be proven that L and D rhamnose signals would be separated using this CE method. The 
electropherogram of all seven references showed a very good base-line separation. Therefore, 
it is most likely that a D-rhamnose would show at least a minimal separation from the L 
diastereoisomer, to allow the determination of the absolute stereochemistry. Jürgenliemk 2000 
demonstrated different migration times of L-rhamnose and synthesised D-rhamnose, under the 
same CE conditions. 
CE can not only be considered as a very strong, but unfortunately also as a relatively 
interference-prone analytical method. It can be observed (see CE figures), that migration 
times vary quite a lot making the direct comparison of single runs not reasonable. This 
problem has been solved by spiking of the samples with known compounds. 
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Fig. 3.39: Electropherogram of the reference sugar mixture (L-rhamnose, D-arabinose, L-
arabinose, L-glucose, D-glucose, L-galactose and D-galactose)  
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Fig. 3.40: Electropherogram of the monosaccharides, after hydrolysis of compound 8 and 
derivatisation, signifying the presence of rhamnose, arabinose and glucose 
 
 
 
 
 
 
migration time [min]
0 5 10 15 20 25 30
ab
so
rb
an
ce
 a
t 2
00
 n
m
 [m
A
U
]
0
5
10
15
20
25
 
 
Fig. 3.41: Electropherogram of the reference sugar mixture spiked with derivatized sugars 
obtained after hydrolysis of compound 8, confirming the presence of L-rhamnose, L-
arabinose and D-glucose in compound 8. 
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Fig. 3.42: Electropherogram of the monosaccharides, after hydrolysis of compound 9 and 
derivatisation, signifying the presence of rhamnose and galactose 
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Fig. 3.43: Electropherogram of the reference sugar mixture spiked with derivatized sugars 
from compound 9, signifying the presence of L-rhamnose and D-galactose in compound 9. 
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3.2 Summary and short discussion on isolation and structure elucidation 
Thirteen pure compounds have been isolated from the rhizomes of R. aculeatus, nine steroidal 
saponins and four phenolic compounds.  
It is known that main constituents of the rhizomes from Butcher's Broom are steroidal 
saponins. Therefore, it was expected that mainly this type of natural products would be 
isolated during this research. Several compounds from all types of steroidal saponins 
(ruscogenin-type, neoruscogenin-type, ruscoside-type) have already been reported in several 
papers by Mimaki et al. 1998 a/b/c, 1999, 2003, 2008. Although the spectrum of these 
compounds was considered to be very broad, it was not primarily expected that new saponins 
from R. aculeatus would be isolated. The goal of this study was to isolate as many as possible 
to get a certain database of the saponins which should then be tested in various cell assays. 
Nevertheless, three new saponines have been isolated (see compounds 4, 6 and 7). Therefore, 
a possibility of finding some other new compounds should be taken into account. 
Several problems occurred during the isolation process, mainly because of the presence of the 
high number of different compounds. This is also the key reason, for making so many 
isolation steps necessary, in order to get pure saponins (isolation procedure, p. 36). 
Compound 2 (p. 56) was found to be a 22-O-methoxy derivative of 3 (p. 57). After isolation 
of 2 (isolation procedure, p. 36), the compound was freeze-dried in order to obtain a water-
free powder. After dissolving it in water, freezing and application to the freeze dryer, 2 was 
dried over night to get a white amorphous powder. A TLC of the dried product was made 
where two clear spots, the original and a lower one, were observed and thus the compound 
must have de-composed during the freeze-drying process.  
 
Due to a very high amount of saponins in the extracts from the rhizomes of Butcher's Broom, 
isolation of other constituents, such as phenols, has been neglected up to now. Single reports 
on the identification of phenolics can be found in literature (El Sohly et al. 1975), but no 
thorough analysis or isolations have been performed so far.  
Four pure phenolic compounds have been isolated during this work. Two of them were 
identified as novel constituents with an unusual skeleton. According to IUPAC, this skeleton 
should be named as a 3-phenyl-2,3-dihydrobenzoxepin. Since the base structure is classified 
as a new biosynthetic product found in R. aculeatus, a combined name 'ruscozepines' was 
selected for this new type of compounds (see compounds 11 and 14). Yet, absolute 
stereochemistry of 11 and 14 has still to be determined via CD spectroscopy. A possible 
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biosynthetic pathway of ruscozepines could be a dimerisation of two phenethyl alcohols as 
indicated in Fig. 3.44, p. 106. The isolation of compound 12 can support this theory. 
 
 
Fig. 3.44: General ruscozepine structure indicating a possible coupling of two phenethyl 
alcohols. 
 
Compound 10 (esculin) is a well known and relatively widespread coumarin which is also 
present in Horse chestnut (Aesculus hippocastanum) and Sweet Clover (Melilotus officinalis). 
Interestingly, all three plants are used in treatment of CVDs. This was the first report of 
esculin in Butcher's Broom. Presence of esculin in our fractions was determined very easily, 
due to the intensive light blue fluorescence under UV at 366 nm. 
To summarize, reinvestigation of compounds from R. aculeatus are still a new and very 
interesting field of research. A variety of further compounds have also been detected during 
the fractionation of PRF. Therefore, it would be reasonable to focus on the isolation of 
phenolic compounds from R. aculeatus to broaden the marginal knowledge about this group. 
For further thorough analysis and isolation a higher amount of the starting material is 
absolutely necessary.  
All isolates with analytical data from this research work have been gathered in Table 3.13, 
p.107.  
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Compound 
Anisaldehyde 
coloration 
MS data UVmax[nm] [α] 24D [
0] 
1, deglucoruscin green 705 [M-H]- 202 -78.3 
2, 22-O-
methyldeglucoruscoside 
green 899 [M-H]- n/a n/a 
3, deglucoruscoside green 885 [M-H]- n/a n/a 
4, 3'-O-acetyl-4'-O-sulfo 
deglucoruscine 
green 827 [M-H]- 202 -93.4 
5, 1-O-sulfo ruscogenin green 509 [M-H]- 202 -53.2 
6, 4'-O-(2-hydroxy-3-
methylpentanoyl)-deglucoruscin 
green 819 [M-H]- 202 -34.7 
7, 4'-O-acetyl-deglucoruscin green 747 [M-H]- 202 -39.5 
8, ruscin green 867 [M-H]- 201 -91.0 
9 * green 737 [M-H]- 202 -102.0 
10, esculin yellow 339 [M-H]- n/a n/a 
11, ruscozepine A purple 
254.0943 
[M+] ** 
222 
267 
300 
n/a 
12, 1-(2- hydroxyethyl)-3,4-
dihydroxy benzene 
brown 153 [M-H]- 
224 
279 
n/a 
14, ruscozepine B purple 
284.1049 
[M+] ** 
230 
273 
307 
-98.9 
*** 
Table 3.13: Overview of compounds isolated from Ruscus aculeatus with some analytical 
data. * - full name see p., ** - HR-MS data, *** - Compound 13 was excluded since it was 
identified as a mixture of diastereoisomers. 
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3.3 Quantification of the extracts and fractions  
3.3.1  Saponin quantification 
Quantification of the saponins in extract and fractions from Butcher's Broom was performed 
according to European Pharmacopoeia (Ph. Eur.). 
Weights used for the quantification procedure were chosen considering the sample to starting 
material (rhizomes) ratio. MeOH extract represented 25% of the rhizomes dried weight, 
therefore 0.5 g of MeOH extract (instead of 2 g of rhizomes according to Ph. Eur.) were used 
for quantification of the methanolic extract. After liquid/liquid partitioning of the methanolic 
extract, for n-BuOH fraction 0.15 g (29.7% of MeOH) and for water fraction 0.29 g (57.4% of 
MeOH) were used. 0.12 g of PPF (80.3% of n-BuOH) and 0.01 g of PRF (7.5% of n-BuOH) 
were also quantified concerning their saponin content.  
Content of saponins was calculated as ruscogenins (neoruscogenin and ruscogenin) and was 
determined by the comparison of the peak areas after HPLC analysis. Ruscogenins CRS (5 
mg/100 ml MeOH; 3.02 mg neoruscogenin and 1.91 mg ruscogenin) were used as an external 
reference. Saponin content of the MeOH extract (2.91 g saponins/100 g MeOH extract) was 
set as the 100% value. Part of the saponins was lost during the liquid-liquid chromatography. 
Results of the saponin quantifications are summarized in Fig. 3.45 and Fig. 3.46. 
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Fig. 3.45: % of saponins calculated as ruscogenins (ruscogenin + neoruscogenin) and 
expressed as the percent of saponins determined in MeOH extract (2.91 g/100 g of MeOH 
extract); n = 3; mean ± SD. 
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Fig. 3.46: % of saponins calculated as ruscogenin and neoruscogenin and expressed as the 
percent of saponins determined in single fractions; n = 3; mean ± SD. 
 
 
From Fig. 3.45, p. 108, it is clear that most of the saponins from the methanolic extract stayed 
in the n-BuOH fraction after the liquid-liquid partitioning. As observed on a TLC plate (Fig. 
3.1, p. 46), most of the steroid saponins from the n-BuOH fraction accumulated in fraction 
PPF after Sephadex fractionation II (p. 33). Therefore, fraction PPF was used for the isolation 
of steroid saponins. Nevertheless, the content of the saponins in PRF was relatively high 
(22.5%). But considering the high molecular weights of saponins and a very low yield of 
fraction PRF (7.5% of n-BuOH), it can be concluded, that steroid saponins with a high 
molecular weight most probably contribute to the total weight of fraction PRF. This was 
confirmed by TLC analysis (Fig. 3.1, p. 46) of fraction PRF, where only few typical red spots 
were observed under UV after derivatization with anisaldehyde reagent. 
The initial MeOH extract showed the presence of both ruscogenin and neoruscogenin-type 
saponins. The content of neoruscogenin-type was slightly higher in comparison to ruscogenin-
type saponins (Fig. 3.46, p. 109). Interestingly, all fractions produced from the initial 
methanolic extract showed much higher percent of ruscogenin-type saponins, which got even 
higher with further fractionation. On the other hand, during this thesis, we were able to isolate 
mainly neoruscogenin-type saponins. Due to this phenomenon, some problems should be 
considered. It is not only very difficult to isolate compounds from unstable extracts, but also 
makes extraction, fractionation and isolation under different conditions questionable and 
irreproducible. It is possible that the use of modified methods leads to completely different 
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fractions and even compounds. In order to standardize such procedures, exact analytical 
conditions should be specified. 
 
3.3.2 Quantification of total phenolic compounds 
Quantification of all phenolic compounds was peformed according to quantification of the 
phenols in Ph. Eur. monography of Tormentillae rhizoma (Ph. Eur. modified by Glasl 1983). 
Same as for saponins, approximate weights of the analysed samples were determined by the 
sample to starting material (rhizomes) ratio (Quantification of saponins, p. 108). Results of 
the quantification of phenolic compounds are gathered in Fig. 3.47 and Fig. 3.48.  
As for saponins, most of the phenolic compounds were found in n-BuOH extract after the 
liquid-liquid partition from MeOH extract. Further fractionation of n-BuOH fraction to PPF 
and PRF gave an equal distribution of phenolics with a slightly higher content in PRF. It is 
important to know that fraction PRF was described as 'rich on phenolics' due to higher amount 
of such compounds in single fractions (Fig. 3.48, p. 111). As described before (quantification 
of saponins, p. 108), there are major differences between the weight of PPF and PRF. Same 
amount of phenolics in much smaller fraction PRF means that percentage of these compounds 
is much higher than in PPF, which can be observed in Fig. 3.48.  
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Fig. 3.47: % of all phenolic compounds expressed as the percentage of the phenolic 
compounds determined in MeOH extract (1.50 g/100 g of MeOH extract); n = 3; mean ± SD.   
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Fig. 3.48: % of all phenolic compounds expressed as the percentage of the phenolic 
compounds determined in single fractions; n = 3; mean ± SD. 
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3.4 Investigation of origin of C-22 hydroxy- and methoxylated compounds 
As described for compound 2 (p. 56) NMR experiment of decomposed 2 confirmed the 
presence of two very similar compounds. ESI-MS experiment of this mixture gave two 
signals: 885 [M-H]- and 899 [M-H]- suggesting that original compound 2 has been de-
methylated to 3, resulting in a mixture of 2 and 3. Same phenomenon has been observed by 
Kite et al. If the transformation from C-22-methoxy- to more stable C-22-hydroxy- compound 
occurs in a neutral and low-energy environment, a very important question needs to be 
answered. Why should R. aculeatus synthesise unstable C-22-methoxy compounds and 
prevent demethylation to hydroxyl derivatives in aqueous solution? Therefore, several reports 
about C-22-methoxylated products (Mimaki et al. 1998 b) need to be re-analyzed, due to the 
high probability that reported compounds are only artefacts of the isolation process. MeOH, 
as one of the main solvents used for extraction and chromatography, could be the reason for 
the generation of artefacts. In order to investigate this phenomenon, further analysis including 
compound 3 and extracts from R. aculeatus have been performed. 
 
3.4.1 Inert extraction and LC-MS analysis of the extracts 
In order to avoid influence of the solvent on the compounds from theButcher's Broom extract 
and thereby avoiding artefacts, rhizomes were extracted with solvents replacing MeOH and 
water (Materials & Methods, p. 38).  
 
Extracts (n-BuOH, H2O) were analysed using LC-MS (ESI-MS) coupled experiment. Due to 
previous reports about chromatographic problems using extracts from Butcher's Broom (Kite 
et al. 2007), three different HPLC methods (p. 39) were tested to optimize the quality of 
separation on the RP-18 column. First, acetic acid was used to acidify solvents used for liquid 
chromatography (H2O/ACN). Due to poor separation, 1% of acetic acid was exchanged by 
0.1% of formic acid without further change of the HPLC method. A better, but still not 
satisfactory separation had been observed. Therefore, the second method was optimized by 
increasing the flow and extending the gradient from 25 to 40 min. Method MS 3 (p. 39) was 
by far the best method used for LC-MS analysis of the extracts. 
To analyse, whether extracts from R. aculeatus originally contain both C-22 methoxylated 
and hydroxylated furostanols, extracts were analyzed concerning the presence of ions with 
RESULTS & DISCUSSION 
 113
m/z 886 for C-22 hydroxy- and 900 for C-22 methoxy-compound. Since acetic acid and 
formic acid were used as modifiers in this experiment, m/z signals of adducts [M + CH3COO-] 
and [M + HCOO-] were expected. Interesting molecular weights for the pseudomolecular 
ions, when using formic acid, were therefore m/z 931 and 932 for compound 3 as well as m/z 
945 and 946 for compound 2. With acetic acid as modifier, relevant peaks were m/z 945 and 
946 for compound 3 and m/z = 959 and 960 for compound 2.  
In all experiments, including all three HPLC methods, only the presence of compound 3 could 
be observed. When using acetic acid as the modifier, m/z 945 [M + CH3COO-] together with 
appropriate pseudomolecular ion at m/z 885 [M-H]- were found. With formic acid m/z 931 [M 
+ HCOO-] together with appropriate pseudomolecular ion at 885 [M-H]- were detected. No 
trace of compound 2 was found in any of the extracts using all three methods (see figures 
from Fig. 3.49, p. 113 to Fig. 3.56, p. 117)  
 
 
 
 
 
Fig. 3.49: ESI-MS signals for compound 2 ([M-H]- and [M + CH3COO-]) after HPLC-MS 
analysis using MS 1, showing the presence of compound 2 in n-BuOH and H2O extract. 
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Fig. 3.50: HPLC-MS analysis of n-BuOH extract using MS 2, showing the HPLC 
chromatogram with observed ions of adducts of compounds 2 and 3. 
 
 
 
 
 
Fig. 3.51: HPLC-MS analysis of H2O extract using MS 2, showing the HPLC chromatogram 
with observed ions of adducts of compounds 2 and 3. 
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Fig. 3.52: HPLC-MS analysis of n-BuOH extract using MS 3, showing the HPLC 
chromatogram with observed ions of adducts of compounds 2 and 3. 
 
 
 
 
 
 
Fig. 3.53: HPLC-MS analysis of H2O extract using MS 3, showing the HPLC chromatogram 
with observed ions of adducts of compounds 2 and 3. 
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Fig. 3.54: HPLC-MS analysis of MeOH extract using MS 3, showing the HPLC 
chromatogram with observed ions of adducts of compounds 2 and 3. 
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Fig. 3.55: HPLC-MS analysis of PPF fraction using MS 3, showing the HPLC chromatogram 
with observed ions of adducts of compounds 2 and 3. 
   
  
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44
Time (min)
0
10
20
30
40
50
60
70
80
90
100
0
10
20
30
40
50
60
70
80
90
100
Re
lat
ive
 A
bu
nd
an
ce
0
10
20
30
40
50
60
70
80
90
100
11.61
29.36
11.9411.09
26.4817.62 29.9617.0412.14 34.26
22.438.36 21.676.393.48 30.8925.81 34.979.362.14 41.2036.35 44.99
11.61
12.09 31.4614.74 21.50 32.446.46 19.03 26.9315.607.93 30.19 34.2923.713.66 10.59
5.13
30.16
9.96 28.29
12.87 27.698.24 15.07 21.00 26.56
32.3922.20
16.5013.99 19.6712.09 34.62
4.59 5.71 23.38 24.5518.39 32.893.08 7.74 8.49 25.00
34.86
NL:
1.91E5
Base Peak 
 MS barb03
NL:
1.91E5
m/z= 
931.1-
932.1  MS 
barb03
NL:
3.06E3
m/z= 
945.1-
946.1  MS 
barb03
HPLC chromatogram 
HPLC chromatogram with MS signals 
for m/z 931/932, 3 [M + HCOO-] 
HPLC chromatogram with MS signals 
for m/z 945/946, 2 [M + HCOO-] 
HPLC chromatogram 
HPLC chromatogram with MS signals 
for m/z 931/932, 3 [M + HCOO-] 
HPLC chromatogram with MS signals 
for m/z 945/946, 2 [M + HCOO-] 
RESULTS & DISCUSSION 
 117
 
 
Fig. 3.56: ESI-MS signals for compound 2 ([M-H]- and [M + HCOO-]) after HPLC-MS 
analysis using MS 2 and MS 3, showing the presence of compound 2 in n-BuOH and H2O 
extract. 
 
 
 
3.4.2 Transformation of C-22 hydroxy- to C-22 methoxylated compound 
The idea of this experiment was to observe, whether the compound 3 will transform from C-
22 hydroxy- to C-22 methoxy-compound, when incubated in MeOD. If conversion occurred, 
several changes in the chemical shifts should be observed. By integration of the 'new' signals 
a kinetic of the transformation should be determined.   
After measurment of 1H experiments for several weeks, indeed some changes have been 
observed (Fig. 3.57, p. 120), but transformation at room temperature was found to be very 
slow. After incubation of compound 3 in MeOD for 6 months, solvent has been removed and 
the sample was again dissolved in pyridine d-5. 1 and 2D NMR spectra were measured to get 
spectra comparable to those of compound 3. Additionally, sample was submitted to ESI-MS 
analysis. Furthernore, sample was dissolved in water for three days, then dried and again 
submitted to NMR analysis. 
NMR data of the mixture was compared to those of the decomposed compound 2 performed 
as 2 was isolated (Table 3.14, p. 119). The results of NMR analysis, especially compared to 
   
 
    [ ]
450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
 A
bu
nd
an
ce
931.5
932.4
933.5
885.5
886.5
934.5927.5
999.7935.4 1040.9810.7 1094.2750.7 1140.4577.0 843.4705.5687.5656.5
RESULTS & DISCUSSION 
 118 
NMR data of compound 2 decomposed in water, were confusing. As it can be seen from 
Table 3.14, all the signals, including non-overlapping double signals, are completely identical 
to those of decomposed compound 2. The only difference is a missing methyl group signal in 
carbon spectrum of our test sample. 
Accordingly, ESI-MS could not confirm the presence of both 2 and 3, meaning the 
transformation from compound 3 to 2 did not occur. Solely peaks with m/z 885 and 887 [M-
H]- were found, the former belonging to [M-H]- of 3. Second signal probably indicates the 
presence of a compound with an exchange of two protons with deuterium atoms in MeOD. 
Literature reports on the methylation of the C-22 hydroxyl group of furostanol saponins after 
incubation in MeOD (Lee et al. 2009) could not be confirmed. Observations on the kinetics 
measured in proton spectrum did not unveil any clear results, which could lead to final 
conclusions about the transformation. Like displayed in Fig. 3.57, p. 120, two major peak 
changes have been observed during the six months incubation in MeOD. Unfortunately, due 
to the high peak overlapping, no signal assignment was possible. After dissolving the sample 
in water for three days, observed mixture transformed back to compound 3, according to the 
NMR spectra taken in pyridine after drying the sample. 
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Table 3.14:  A: 13C (δ in ppm) signals of compound 2 partially decomposed 
  to 3 after freeze drying 
  B:  13C (δ in ppm) signals of compound 3 after 6 months  
  incubation in MeOD 
 
Experiment (150 MHz, 296 K) showed for both samples identical signals, 
except for the MeO- group present in mixture A (marked red). 
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Fig. 3.57: Changes of NMR proton peaks at 0.94 and 0.84 ppm for compound 3, incubated in 
MeOD for 6 months at room temperature and measured on Bruker Avance III 600 Kryo in 
MeOD at room temperature. 
 
 
 
Since the transformation from 3 to 2 was excluded via LC-MS experiment, changes observed 
in Fig. 3.57 must have occured due to the interference of the deuterated methanol, causing 
exchange of protons with deuterium. Still, it is hard to believe that shifts of 13C signals of this 
mixture were completely identical to those from the mixture of compounds 2 and 3, except for 
the methyl group (Table 3.14, p. 119). 
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3.5 Cell culture assays 
As described before (Introduction, p. 7), extracts from R. aculeatus have shown promising 
results in the treatment of CVI and some other chronic vascular diseases. It has also been 
suggested (Introduction, p. 8) that inflammation plays a key role in development of these 
diseases. Endothelial hyperpermeability and expression of endothelial cell adhesion molecules 
are two very important features of inflammatory response. Therefore, ICAM-1 expression 
inhibition and macromolecular permeability assay, using human microvascular endothelial 
cells, were performed in order to determine the activity of fractions and compounds from 
Butcher's Broom. The studies have been broadened by additional experiments, such as 
viability assays and tests, where the influence of testing samples on endothelial cells has been 
observed. Results from these investigations could certainly contribute to the better knowledge 
of treatment of vascular diseases using products from R. aculeatus.   
 
3.5.1 ICAM-1 expression inhibition assay 
The results from ICAM-1 assays showed that methanolic extract and fractions from the 
extract influence the expression of adhesion molecules. Furthermore, several single 
compounds isolated from Butcher's Broom showed activity in this assay.  
Extracts and fractions have all been tested relatively to the yields from fractionation, where 
MeOH extract was set to 100%. Parthenolide was used as a positive control. As it is toxic at 
10 µM (cell cell death observed under microscope), a 5 µM solution was used in later assays 
with isolated compounds. 
Interestingly, all extracts showed better inhibition of ICAM-1 expression at lower 
concentrations (Fig. 3.58, p. 122). Plausible explanation is that higher concentrations 
probably promote inflammation and thereby increase the expression of ICAM-1 molecules. 
Fractions PPF and PRF, both produced from n-BuOH fraction, showed inhibition at relatively 
low concentrations, especially PRF by inhibiting the expression down to 73% at 
concentrations of 0.2 and 0.02 µg/mL, respectively (Fig. 3.59, p. 122). 
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Fig. 3.58: Inhibition of ICAM-1 expression (%) after 24 h with MeOH extract, n-BuOH and 
H2O fraction on the HMEC-1 cells; parthenolide (10 µM) was used as positive control; n = 3; 
mean ± SD; *** p < 0.001, ** p < 0.01.  
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Fig. 3.59: Inhibition of ICAM-1 expression (%) after 24 h with PPF and PRF fractions on the 
HMEC-1 cells; parthenolide (10 µM) was used as positive control; n = 3; mean ± SD;          
*** p < 0.001.  
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Compounds 1, 3, 5, 6, 7, 8, 9 and 10 (50 µM, 10 µM, 1 µM), together with neoruscogenin, 
were also tested in ICAM-1 assay. Several compounds showed slight inhibition of ICAM-1 
expression with ruscin (8) being the most effective. At concentration 50 µM, ruscin inhibited 
the expression down to remarkable 55% (Fig. 3.65, p. 126). Compounds 1 and 9 at 50 µM 
increased the expression significantly (Fig. 3.60, p. 123 and Fig. 3.66, p. 126). The same was 
observed with compound 6 at 10 µM. At 50 µM, 6 caused cell death of the HMECs (Fig. 
3.80, p. 136), therefore inhibition of ICAM-1 expression could not be measured. Compound 3 
showed no activity.  
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Fig. 3.60: Inhibition of ICAM-1 expression (%) after 24 h with compound 1 on the HMEC-1 
cells; parthenolide (10 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001. 
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Fig. 3.61: Inhibition of ICAM-1 expression (%) after 24 h with compound 3 on the HMEC-1 
cells; parthenolide (10 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001. 
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Fig. 3.62: Inhibition of ICAM-1 expression (%) after 24 h with compound 5 on the HMEC-1 
cells; parthenolide (5 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001,                
* p < 0.05. 
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Fig. 3.63: Inhibition of ICAM-1 expression (%) after 24 h with compound 6 on the HMEC-1 
cells; parthenolide (5 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001. 
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Fig. 3.64: Inhibition of ICAM-1 expression (%) after 24 h with compound 7 on the HMEC-1 
cells; parthenolide (5 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001,                
* p < 0.05. 
*** 
*** 
*** 
*** 
*** 
* * 
Compound 6 
Compound 7 
RESULTS & DISCUSSION 
 126 
2,9
100,0 91,9
104,3
55,2
31,2
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
Control TNF Parthenolide 50µM 10µM 1µM
IC
A
M
-1
 e
xp
re
ss
io
n 
   
   
  
 
Fig. 3.65: Inhibition of ICAM-1 expression (%) after 24 h with compound 8 on the HMEC-1 
cells; parthenolide (5 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001,                    
* p < 0.05. 
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Fig. 3.66: Inhibition of ICAM-1 expression (%) after 24 h with compound 9 on the HMEC-1 
cells; parthenolide (5 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001,                
** p < 0.01, * p < 0.05. 
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Fig. 3.67: Inhibition of ICAM-1 expression (%) after 24 h with compound 10 on the HMEC-1 
cells; parthenolide (10 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001,              
** p < 0.01. 
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Fig. 3.68: Inhibition of ICAM-1 expression (%) after 24 h with neoruscogenin on the HMEC-
1 cells; parthenolide (5 µM) was used as positive control; n = 3; mean ± SD; *** p < 0.001, * 
p < 0.05. 
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3.5.2 Macromolecular permeability assay 
The hyperpermeability assays were performed by E. Willer and Dr. R. Fürst of the Institute of 
Pharmaceutical Biology, Ludwigs-Maximilians-University München, Germany. 
Hyperpermeability of endothelial cells was induced by stimulating a confluent grown 
monolayer with thrombin. Thrombin causes disruption of endothelial barrier and thereby an 
increase in permeability. FITC-labelled dextran was used for the measurement of induced 
permeability. Values of the cells, treated only with dextran, were set as control value (100% 
diffusion). Influence of compounds on cells treated with thrombin was compared to the 100% 
value. Completely untreated cells were used as a negative control.  
Compounds tested in this assay were 1, 5, 6, 8, 9, 10, 11, 12 and neoruscogenin at 100 µM, 10 
µM, 1 µM and 0.1 µM (incubated for 60 min). In general, none of the compounds showed 
strong reduction of thrombin induced hyperpermeability. Nevertheless some of the samples 
significantly diminished effects of thrombin. At a certain concentration, most of the tested 
saponins caused a remarkable increase in permeability, which was observed as even higher 
than permeability of the monolayer treated with thrombin. This phenomenon can probably be 
explained by the property of the saponins to promote a detergent effect at high concentrations. 
This leads to cell membrane disorganization and thereby higher permeability. This hypothesis 
was confirmed by lacking effects of aglycone neoruscogenin and sulfated aglycone 
ruscogenin (5). Interestingly, saponin 9 did not show increase in permeability in none of the 
testing concentrations. Even more, 9 significantly reduced thrombin induced permeability at 1 
µM, 10 µM and 100 µM. Most effective compounds were ruscin (Fig. 3.73, p. 131), 
compound 5 (Fig. 3.71, p. 130) and deglucoruscin (Fig. 3.70, p. 129) at 10 µM. At higher 
concentrations (100 µM), compounds 1 and 8 both dramatically induced permeability of the 
dextran. Compound 10 (esculin) at 10 µM also significantly decreased the thrombin induced 
hyperpermeability (Fig. 3.75, p. 132).  
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Fig. 3.69: Permeability assay for neoruscogenin after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE. 
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Fig. 3.70: Permeability assay for compound 1 after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE; *** p < 0.001. 
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Fig. 3.71: Permeability assay for compound 5 after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE; ** p < 0.01. 
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Fig. 3.72: Permeability assay for compound 6 after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE; *** p < 0.001, * p < 0.05. 
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Fig. 3.73: Permeability assay for compound 8 after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE; *** p < 0.001, ** p < 0.01, * p < 0.05. 
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Fig. 3.74: Permeability assay for compound 9 after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE; *** p < 0.001, ** p < 0.01, * p < 0.05. 
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Fig. 3.75: Permeability assay for compound 10 after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE; * p < 0.05. 
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Fig. 3.76: Permeability assay for compound 11 after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE. 
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Fig. 3.77: Permeability assay for compound 12 after 60 min; expressed as percent of the 
thrombin value (100%); n = 3; mean ± SE. 
Compound 12 
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3.5.3 Viability assay  
Confluent HMECs, incubated with methanolic extract and compounds from R. aculeatus, 
were treated with MTT solution in order to determine the influence of the samples on viability 
of endothelial cells according to Mosmann 1983. 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, shortly MTT, is a yellow coloured tetrazole, which is reduced 
by the mitochondrial reductase of living cells to purple coloured formazan (Fig. 3.78, p. 134). 
Control cells were also treated with MTT in order to obtain reference data, which was 
compared with the data from the samples. After dissolving the purple formazan, absorbance 
was measured on SpectraFluor plus plate reader at 560 nm. Higher absorbance correlates with 
higher viability, higher cell number or increased reductase activity since more MTT has been 
reduced to formazan. 
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Fig. 3.78: Mitochondrial trasformation of yellow tetrazole (MTT) to purple coloured 
formazan. 
 
 
MTT viability assay is often used for measurement of cytotoxicity. But it is important to keep 
in mind that viability assays only show the changes in metabolic activity of the cells. It is 
possible that the number of viable cells remains the same as in control, while significant 
changes in metabolic activity are observed.  
 
MeOH extract was tested in concentrations of 1000 µg/mL, 100 µg/mL, 10 µg/mL and 1 
µg/mL. None of the samples showed decrease of viability (Fig. 3.79, p. 135). The extract 
caused slight but significant (p < 0.01) increase of formazan production at 100 µg/mL. 
Mitochondrial reductase 
 
+ 2 e- 
RESULTS & DISCUSSION 
 135
Compounds 1, 3, 5, 6, 7, 8, 9, 10 and neoruscogenine (50 and 10 µM) were investigated in 
MTT viability assay. Parthenolide (50 or 10 µM) was also tested. Although the structure 
similarity of steroid saponins might suggest comparable influence on viability, different 
results have been observed (Fig. 3.80, p. 136). Compound 6 (50 µM) was found to be toxic. 
Viability of the cells was decreased to 12.9% and cell death of majority of the cell was 
observed under microscope.  
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Fig. 3.79: MTT viability assay after 24 h with MeOH extract on the HMEC-1 cells; n = 3;  
mean ± SD; ** p < 0.01. 
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Fig. 3.80: MTT viability assay after 24 h with compounds 1, 3, 5, 6, 7, 8, 9, 10, 
neoruscogenine (50 and 10 µM) and parthenolide (10 µM) on the HMEC-1 cells; n = 3;  mean 
± SD;      *** p < 0.001, ** p < 0.01. 
 
 
 
3.5.3.1 IC50 value of compound 6 
IC50 value of compound 6 was determined using MTT viability assay. Half maximal 
inhibitory concentration is used to quantify efficacy of compounds in inhibitory assays. Since 
6 showed cytotoxicity against HMECs at 50 µM, calculation of IC50 value was relevant. 
Assays gave IC50 value for compound 6 at 33.0 ± 2.0 µM (Fig. 3.81; n = 3; mean ± SD).    
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Fig. 3.81: IC50 value calculation curve for compound 6 using a logarithmic scale (x axis); n = 
3 
 
 
 
3.5.4 Influence of compounds 1 and 8 on the HMEC-1 cell number 
3.5.4.1 Cell staining using CV 
Saponins deglucoruscin and ruscin (1 and 8) were tested on the confluent HMECs to get data 
on their influence on the cell number (Fig. 3.82, p. 138). Crystal violet (CV) is a violet dye 
that stains DNA of the cells nucleus. After removing excess of CV, cells have been treated 
with sodium citrate solution in order to dissolve CV accumulated in cells. Control cells were 
pre-incubated only with growth medium and used for comparison. Lower absorption values of 
the cells treated with compounds would mean that less cell nuclei were stained and therefore a 
reduced number of cells were present. 
Results showed that both compounds have influence on the cell number (Fig. 3.82, p. 138). 
Compound 1 (deglucoruscin) showed minor and unsignificant effect on the cells. On the other 
hand, absorbance values for compound 8 (ruscin) significantly differed from the control. 
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Consequently, 8 reduced the number of cells in the wells and can thereby be described as 
toxic at 50 µM. 
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Fig. 3.82: CV cytotoxicity assay after 24 h with compounds 1 and 8 (50 µM ) on the HMEC-1 
cells; expressed as percent of the control value (100%); n = 3; mean ± SD; *** p < 0.001. 
 
 
 
3.5.4.2 Cell counting assay using Trypan blue (24-well) 
Cell counting experiment was performed in order to confirm the results from the assay using 
CV staining. Trypan blue is a dye that does not enter viable cells and only passes the 
membranes of dead or damaged cells. In this assay, we obtained absolute cell count of the 
HMECs present in each well, where the number of the control cells (incubated with medium) 
was compared to the count of the cells pre-incubated with compounds 1 and 8.  
Fig. 3.83, p. 139 clearly shows that compound 8 significantly reduced the number of HMECs 
present in wells in comparison with the untreated control cells. Therefore, it has been 
concluded that 8 is toxic at 50 µM. 
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Fig. 3.83: Trypan blue cell counting cytotoxicity assay after 24 h with compounds 1 and 8 (50 
µM ) on the HMEC-1 cells in 24-well plates; expressed as percent of the control value 
(100%); n = 3; mean ± SD; *** p < 0.001. 
 
 
 
3.5.4.3 Cell counting assay using Trypan blue (6-well) 
Same procedure as in 24-well plates was performed in 6-well plates. It was observed that 
HMECs can be easier removed and counted from the 6-well than from the 24-well plates. 
Therefore, it was expected that better results with lower standard deviations would be 
measured in the assay with 6-well plates. Fig. 3.84, p. 140, shows that results of the assay 
using 6-well plates correlate with the results from the first assay using 24-well plates. Results 
for the control cells and compound 1 were almost identical to the values and standard 
deviations from the first trypan blue assay. Compound 8 gave different percent of the cells 
after 24 h in comparison to the control. As in the first assay and the CV staining, 8 has 
significantly reduced the number of cells in comparison to the control value and can therefore 
be confirmed as toxic. Since the 6-well assays were easier to handle and the fact that more 
cells could have been removed from 6-well than from 24-well plates, the 6-well assay is 
considered to be more appropriate for cell counting cytotoxicity assays.   
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Fig. 3.84: Trypan blue cell counting cytotoxicity assay after 24 h with compounds 1 and 8 (50 
µM ) on the HMEC-1 cells in 6-well plates; expressed as percent of the control value (100%); 
n = 3; mean ± SD; *** p < 0.001. 
*** 
RESULTS & DISCUSSION 
 141
3.6 Summary and final discussion including the biological assays   
Extracts from R. aculeatus nowadays are mainly used to treat chronic venous diseases, such 
as chronic venous insufficiency (CVI) and hemorrhoids. Bergan 2007 and Bergan et al. 2008 
postulated that inflammation might play the key role in the development of these diseases. 
Several in vitro, in vivo and clinical studies have been performed in order to determine the 
treatment prospects and options of products from Butcher's Broom (Escop). Results of these 
studies using extracts from the underground parts of Butcher's Broom have shown remarkable 
improvements of venous disorders. Therefore, treatment with R. aculeatus has to be 
considered as a good option in the therapy of chronic venous diseases.  
Major constituents of Rusci rhizoma are steroid saponins and several have already been 
isolated (Mimaki et al.1998 a/b/c, 1999, 2003, 2008). Due to the high amount of saponins in 
the rhizomes of Butcher's Broom, it has been believed that they are responsible for the 
positive effects on the symptoms of chronic venous diseases. Rauwald & Grünwald 1991 
have also proven that saponins of Rusci rhizoma can be found in human blood after oral 
administration. These results support the theory that they contribute to the efficacy of the 
extracts. On the other hand, no thorough analysis of other type of compounds, such as 
phenols, has been performed so far. Although amount of these substances in underground 
parts of R. aculeatus is low, the influence of them should be taken into consideration. 
The main goal of this thesis was to isolate compounds from Rusci rhizoma and test them in 
several cell culture assays, which are related to possible targets present in the venous system 
in vitro. Since expression of adhesion molecules and vascular hyperpermeability are 
considered as two very important features of inflammatory response and the fact that 
inflammation is one of the main reasons for development of chronic venous diseases, ICAM-1 
expression inhibition and macromolecular permeability assays have been chosen for our 
research. 
 
In order to separate steroid saponins from other smaller compounds, a method using Sephadex 
LH 20 has been developed (Sephadex fractionation II, p. 33). After repeating the procedure 
for several times, two major fractions have been produced, a 'fraction rich on saponins', also 
described as 'fraction poor on phenolics' (PPF) and a fraction 'rich on phenolics' (PRF). TLC 
overview on the main constituents was confirmed by the quantification of both fractions (p. 
108). Quantification of saponins showed an interesting phenomenon. In Fig. 3.46, p. 109, it 
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can be observed that main MeOH fraction contained similar amount of ruscogenin and 
neoruscogenin-type saponins (1.40% for ruscogenin and 1.53% for neoruscogenin). All 
fractions produced from MeOH extract contained much more ruscogenin than neoruscogenin-
type saponins, suggesting that some chemical transformations occurred. Interestingly, in this 
research work we were able to isolate more of neoruscogenin-type steroid saponins.  
Another interesting observation has been made during the isolation process and has been 
described before by Kite et al. 2007. Compound 2 was identified as a C-22 methoxylated 
deglucoruscoside and was partially transformed into 3 after addition of water. In this case, this 
is a very unusual reaction, where an acetal (ketal) is converted back to hemiacetal under 
aqueos conditions without addition of an acid, which is normally required. Also surprising is 
the reaction kinetic as over night approx. half of compound 2 decomposed into compound 3. 
Since this transformation occurs very fast and under neutral conditions, it is questionable 
whether the C-22 methoxylated compounds really exist as natural product of R. aculeatus. It 
is hard to believe that a plant would produce and accumulate compounds which are instable in 
water. It would be energetically non-favourable. More reasonable explanation would is that 
C-22 methoxylated compounds are only artefacts and side products of the extraction and 
isolation procedure. Methanol has been used in chromatography as one of the main solvents. 
This indicates the possibility of methoxylation of the hydroxyl group at the C-22.  
Some tests on the extracts and compounds from Butcher's Broom were performed in order to 
investigate this phenomenon. To get inert extracts (p. 112), the use of water and methanol was 
excluded from the extraction procedure. DCM and EtOAc were used to defat the plant 
material and n-BuOH to get the main extract. Extraction with water was performed to obtain a 
parallel sample, in order to observe the influence of water on the extract. The results of LC-
MS analysis (p. 112) showed that none of the analysed samples contained compound 2. 
Consequently the methoxylated product was not present in the starting material. Compound 3 
(C-22 hydroxylated) was found in all investigated samples. The same result was obtained for 
fraction PPF, meaning that methanol did not have an influence on the compounds in the initial 
fractionation. On the other hand, compound 2 was isolated during this research and has also 
been reported before (Mimaki et al. 1998 b). This suggests that at some point of the isolation, 
compound 3 partially transformed into 2. Every further fraction during the fractionation 
process contained fewer compounds, which increased the chance of methoxylation. The 
whole matrix of compounds is far less susceptible to the influence of MeOH than the smaller 
fractions that contain only few substances. All the fractions were also evaporated using a 
rotary evaporator at higher temperatures, which could catalyze the reaction. Considering all 
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these facts and the LC-MS data, it is highly believable that 2 and other potential C-22 
methoxylated compounds are only side products of the isolation and do not occur genuine in 
nature. 
These findings have also implications for the saponin quantification as some of the 
compounds in the extract from Butcher's Broom are less stable than others and can thereby 
contribute to the different results of fractionation and isolation.   
Observations of the transformation kinetic from compound 3 to 2 in MeOD at room 
temperature did not show clear results (p. 117). In order to improve this experiment, non-
deuterated MeOH with occasional increase in temperature should be used for incubation of 
compound 3 to simulate conditions similar to those during the isolation process.  
 
Results of all biological assays performed during this research work showed that extracts, 
fractions and compounds from R. aculeatus can have an influence on the human 
microvascular endothelial cells in vitro.  
ICAM-1 inhibition assay simulated part of inflammation process in veins. Expression of 
ICAM-1 molecules at the top of the vascular cells is one of the key features of the 
inflammatory response. In the case of inflammation, molecules such as TNF-α are released in 
order to stimulate the expression of endothelial adhesions cells like ICAM-1, which are 
important for the transmigration of the leucocytes into the tissue (Sprague & Khalil 2009, 
Lawson & Wolf 2009). In the case of chronic inflammation, endothelial activation leads to a 
chronically higher expression of the adhesion molecules, which furthermore resulted into 
inflammation. Inhibiting the expression of such molecules, chronic inflammation could be 
likely reduced. 
After 24 h of incubation, all main extracts (MeOH extract, n-BuOH and H2O fraction) showed 
inhibition of the TNF-α induced ICAM-1 expression at low concentrations. Interestingly, 
high concentrations resulted into an increase of ICAM-1 expression (Fig. 3.58, p. 122). 
Similar results were obtained by testing the PRF and PPF fraction (Fig. 3.59, p. 122). With 
inhibition down to approx. 73% of the maximal expression caused by TNF-α for PRF and 
80% for PPF, these fractions were considered as very promising for further analysis.  
Single compounds also showed certain effect, but not as high as expected from the results of 
the major fractions. Most of the compounds showed only minor and mostly statistically not 
significant inhibition of expression. Most effective compound was ruscin (compound 8), 
which inhibited the expression of ICAMs significantly down to 55% at 50 µM. This is a 
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remarkable result but must unfortunately be observed with cautious, because of the results 
from the viability and cell counting assays (Fig. 3.80, p. 136; Fig. 3.82, p. 138; Fig. 3.83, p. 
139 and Fig. 3.84, p. 140). MTT viability assay of compound 8 showed hyperactivity of the 
cells at 50 µM. Viability value was increased to 140% of the control cells value. Ruscin was 
also tested in the cytotoxicity assays (Fig. 3.82, p. 138; Fig. 3.83, p. 139 and Fig. 3.84, p. 
140) and gave surprising results. Both assays (KV staining, trypan blue cell counting in 6- and 
24-well plates) showed that 8 was toxic at 50 µM, since the cell count significantly dropped in 
comparison to the control cells. It has again been proven that MTT viability assay do not 
match exactly the cytotoxicity assays. Results from both assays can significantly deviate from 
each other. 
A further important finding was the higher activity of the isolated compounds, tested in 
ICAM-1 assay, in comparison to the aglycone neoruscogenin. This suggests that steroid 
saponins from Butcher's Broom are probably more responsible for the effect in venous system 
in comparison to their aglycones. Huang et al. 2008 tested ruscogenin on its activity in a 
similar assay and it was found to be active. It is possible that ruscogenin is more potent than 
neoruscogenin. Furthermore, the assay set-up was also different. An important difference was 
the incubation time, as Huang et al. used an incubation time of only 4 h in comparison to 24 h 
in this assay. To compare the activity of the aglycones, both compounds should be tested in 
the same assay.  
MTT viability assay showed that compound 6 is toxic at 50 µM, since all the cells dissolved 
from the plate. Same was observed during the measurements of the fluorescence by the FACS 
analysis, where no cells were detectable after performing the ICAM-1 inhibition assay. 
Interestingly, compounds 1 and 9 showing no cytotoxicity, do not differ much from 6. For this 
reason, it has been concluded that the side chain on the C-4' of the arabinose in compound 6 
must be responsible for the toxic effect (MTT IC50 = 33.0 ± 2.0 µM). Compounds 1, 6, 8 and 
9 would therefore be eligible for thorough analysis of the mechanism of action. However, a 
possible explanation is that small structural changes contribute to the different intensity of the 
detergent effect. To investigate these aspects, measurements of critical micelle concentration 
or hemolysis can be considered as appropriate assays.  
 
One of the most important aspects of endothelium activation and inflammatory response is 
macromolecular hyperpermeability. Increase in permeability of the vascular cells in veins 
leads to higher permeability for proteins and fluids. In case of CVI, this manifests as edema 
and leads to further activation of endothelium. 
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Influence on permeability of human microvascular endothelial cells was analyzed by 
measuring the influence of compounds from R. aculeatus on the thrombin-induced 
permeability of FITC-labelled dextran through the confluent grown monolayer of HMECs. 
The results of this assay were more remarkable than those in the ICAM-1 assay. Most of the 
compounds showed tendency to decrease the induced permeability, but effects were often not 
significant. Most active compounds were compounds 1, 5 and 8, reducing the permeability of 
the dextran at 10 µM down to 42%, 53% and 52%, respectively, after 1 h of incubation. At 
100 µM all saponins, except for 9, dramatically increased the permeability. Higher 
concentrations of saponins most probably dissolved or damaged the cells and thereby caused 
the increase in permeability through the monolayer. Significant decrease in permeability of 
the FITC-labelled dextran showed also compound 10 at 10 µM (60%) and was thereby the 
only phenolic compound active in this assay.  
Compound 6 showed tendency to induce the permeability at all tested concentrations (Fig. 
3.74, p. 131). MTT viability assay revealed that 6 caused cell death at 50 µM and was thereby 
the only compound that showed such dramatic changes in the MTT assay.  
Unfortunately, not every isolated compound was tested in biological assays. Yields around 1 
mg per sample or less did not allow testing in cell culture assays. Phenols are surely one of the 
most interesting research topics of this thesis, but due to the low amounts no thorough tests 
for activity in selected assays were performed. Much higher amount of the starting material 
should be used for fractionation and isolation of the phenolic compounds to obtain significant 
amounts. 
 
Compounds 1 and 8 showed interesting results in ICAM-1 and MTT assay. In combination 
with the data from the permeability assay no clear conclusions about the activity could have 
been drawn. Ruscin (8) showed high ICAM-1 expression inhibition at 50 µM (Fig. 3.65, p. 
126), but caused high activity of the mitochondrial enzymes in MTT assay like deglucoruscin 
(1) (Fig. 3.80, p. 136). Therefore, cytotoxicity assays based on cell counting were developed 
to determine the influence on the cells and actual cytotoxic effect of the compounds (p. 137). 
In all three assays, it has been proven that 8 is toxic at 50 µM. Possible explanation is the 
attempt to down-regulate mechanisms, which are not vital for the existence (expression of 
ICAM-1 molecules) and up-regulate processes that are used as the last resort to survive, in 
this case mitochondrial activity. This was not the case for compound 1. Since 1 at 50 µM 
showed similar behavior as 8 at 10 µM in ICAM assay, it is possible that toxic concentration 
of compound 1 has not been reached yet. Since the permeability assay showed that 1 greatly 
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increases the permeability through the HMEC monolayer at 100 µM, it would be reasonable 
to test 1 at concentrations between 50 µM and 100 µM in both ICAM and MTT assay, in 
order to get a clear answer about the activity. It is also possible that the other isolated 
saponins show similar effects, but only at different concentrations, which have not been 
included in testing. Furthermore, it has to be considered that in permeability assay, cells were 
stimulated for only 1 h in comparison to ICAM-1 and MTT assay, where 24 h incubation 
times were used.  
From ICAM-1 and permeability assay, it can be concluded that steroid saponins cause partly a 
dose-dependent response, resulting at least to an U-shaped activity curve. At several 
concentrations, tested saponins diminished in vitro stimulated inflammation (higher ICAM-1 
expression via TNF-α and higher permeability via thrombin) but can on the other hand act 
pro-inflammatory and also cause cell death at higher concentrations. In order to describe the 
activity and to get the full dose-dependent curve of single compounds, same assays should be 
performed using diverse concentrations of the compounds. Therefore, higher amounts of the 
selected compounds should be isolated and a higher quantity of starting material should be 
used for fractionation and isolation. 
 
Cell counting assays have shown that the assay using 6-well plates was better to handle with. 
The cells in the 6-well plates were easily resuspended using trypsin/EDTA solution and cell 
scraper. On the other hand, in 24 well plates the cells growing on the edge of the wells could 
not be completely removed, which most certainly influenced the final results. The results in 
both assays showed the same tendency but gave different results for compound 8 at 50 µM. 
There are two factors, which might be the reason for that. It has to be considered that the cell 
count obtained in 24-well assay was too low, due to the cells from the edge that could not be 
counted. For the values of compound 1, which were not significantly different to the values of 
the control cells, this did not cause a great change. For compound 8, where the cell count was 
dramatically reduced down to 45 % in 6-well assay, leaving out the cells from the edge would 
mean a bigger change in the cell count and therefore even lower values in the 24-well assay.  
Second parameter that might influence the results of the cell counting assay is the absolute 
quantity of the compounds to area of the well ratio. In 24-well plates 0.5 mL to 2 cm2 ratio 
was used, which means higher absolute amount of compound per cm2 than in 6-well plates (2 
mL to 9.6 cm2 ratio). This could also contribute to the higher cytotoxic effect measured in the 
24-well assay. Since 6-well assay was better to handle with and all the HMECs were removed 
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from the plate, the cell counting assay using 6-well plates should be considered as more 
appropriate. 
 
During this study it has been proven in vitro that extracts, fractions and compounds from the 
underground part of R. aculeatus could have an influence on the human venous system. In 
vitro assays, such as ICAM-1 expression inhibition and permeability assay, showed that 
isolates from Butcher's Broom have an effect on the inflammatory response of the human 
microvascular endothelial cells, which is suggested to play the key role in the development 
and progression of chronic venous diseases (Bergan 2007 and Bergan et al. 2008). None of 
the compounds could be observed as very potent, but if single constituents and their minor 
activity are considered as only the part of a matrix of substances, the appropriate dose and 
composition of compounds could have a larger impact on the inflammatory response and 
would thereby lead to improvement of chronic venous diseases, such as CVI or hemorrhoids.  
In this thesis, it has also been shown that saponins are more active than the aglycone 
neoruscogenin, which makes studies on R. aculeatus more fascinating and indicating that 
steroid saponins should be included in other experiments, where normally only raw extracts 
have been tested (Escop).  
New compounds have also been found (see compounds 4, 6, 7, 11 and 14 and discussion 
about isolation on p. 105). Among these compounds 11 and 14 showed novel skeleton. It also 
seems to be important to broaden the knowledge about the contribution of phenolic 
compounds from R. aculeatus to the overall efficacy of Butcher´s Broom. 
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